weighted_quality_score,error_percent,quality_rating,weighted_error_percent,completeness_percent,title,weighted_completeness_percent,publisher,schema_version,pid,id,weighted_quality_rating,quality_score
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Primary Elbow Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,b06415af-9151-4ccc-83a1-ab859943fb2b,0092dc60-a0af-4d45-801c-b888210d6609,Not Rated,47.98
69.05,23.26,Bronze,22.22,69.05,PTCL Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,19fa25a7-c15d-441c-b635-ad49043e7a96,0121c132-5be6-414e-853b-885ff301854f,Bronze,72.89
69.84,20.93,Bronze,20.63,69.05,Human Developmental Biology Resource (HDBR),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,399a6d67-7577-4476-a3b6-4bbceb5a8ff7,01470238-7a17-47a5-a131-17178ba26a0a,Bronze,74.06
61.11,23.26,Not Rated,23.81,52.38,Estimating Chronic Respiratory Disease burden in adults in Asian LMICs,46.03,HUB > BREATHE,1.1.7,56130df6-1880-4600-a7a4-afa9a4bcc895,0150353c-d33d-4af0-b177-8ef0adf867f4,Not Rated,64.56
43.65,32.56,Not Rated,34.92,26.19,Paediatric Intensive Care Audit Network - core dataset (admission),22.22,ALLIANCE > HQIP,1.1.7,4ca76471-6970-4ad4-87c7-fae77a98cbf5,0217114b-6847-4aae-9d76-4d52acea2bcc,Not Rated,46.81
67.46,37.21,Not Rated,39.68,66.67,COVID antigen  testing - Pillar 2,74.6,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,1.1.7,c8f2ee14-2831-445d-a207-2f7f932f4735,022cedb4-650d-4566-be41-8d7ed07a5112,Bronze,64.73
69.84,37.21,Not Rated,38.1,69.05,HES Diagnostic Imaging Dataset for CPRD Aurum,77.78,ALLIANCE > CPRD,1.1.7,617f9f54-3fb6-40c3-b391-fe51d1fc7c49,0266f904-b168-488a-a9e7-d318443584ef,Bronze,65.92
83.34,20.93,Silver,20.63,80.95,Unscheduled Care Datamart,87.3,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,a265af2e-40fc-4759-af61-eab293cdad5a,02dceba1-65c7-49e8-a3e2-05e71c1a3033,Silver,80.01
69.84,20.93,Bronze,20.63,69.05,Cam-UroOnc Biorepository,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,21044030-1cd5-46b1-b072-c9959fd330b4,0315886c-f34a-4f1d-8f76-2dfa80a6e949,Bronze,74.06
45.24,32.56,Not Rated,33.33,28.57,The Leicester City and County Chronic Kidney Disease Cohort,23.81,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,1.1.7,4dfec37d-dd24-465f-85ea-30209aff3a26,039c0b29-63f6-4ce9-8d89-87012a52e44f,Not Rated,48.0
87.3,20.93,Gold,25.4,95.24,Annual District Death Extract,100.0,ALLIANCE > SAIL,1.1.7,15cf4241-abad-4dcc-95b0-8cd7c02be999,03db4df3-f482-4bdd-a335-546ffffbeaab,Gold,87.16
67.46,30.23,Not Rated,33.33,59.52,COVIDsortium,68.25,OTHER > UNIVERSITY COLLEGE LONDON,1.1.7,529f126b-660c-4c31-aeb2-765dac1d9df0,03fb3b18-4419-44f7-a035-9ddfecfcadfc,Bronze,64.64
37.3,39.53,Not Rated,39.68,16.67,SOLUS,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,e653b264-3e44-4ed1-a376-86df45db7f72,0477b06f-cbed-4949-982e-ce248a47ed1a,Not Rated,38.57
42.86,34.88,Not Rated,36.51,26.19,National Cardiac Audit Programme - Myocardial Ischaemia National Audit Project (MINAP),22.22,ALLIANCE > HQIP,1.1.7,3558f8a1-6d52-4b59-b513-51c068095bc2,04b1648d-eeb7-4072-8dd2-806c3ae4e20d,Not Rated,45.66
84.13,25.58,Silver,28.57,92.86,North West London COVID-19 Patient Level Situation Report (NWL COVID19 SITREP),96.83,HUB > DISCOVER NOW,1.1.7,ed08c844-343e-44fa-a02d-3ad5ecf25184,04f22c93-53df-440a-a71a-50d6827450bc,Silver,83.64
89.69,18.6,Gold,20.63,95.24,Bowel Screening Wales,100.0,ALLIANCE > SAIL,1.1.7,9f29d47e-4e9a-41b8-b7bc-5ef3570294ef,05716e41-9842-4c07-8ddd-af9f9231e056,Gold,88.32
65.08,20.93,Bronze,20.63,59.52,IBD Registry,50.79,HUB > GUT REACTION,1.1.7,a406d06b-350e-4392-ab4e-b1012e422a34,05eadf79-02a7-4c1f-b1be-93694172a9b3,Not Rated,69.3
69.84,20.93,Bronze,20.63,69.05,INCA Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,edd55990-a616-4a9c-a4a2-38af136a349b,0664f988-276e-4268-af43-1986a3101f38,Bronze,74.06
62.7,20.93,Bronze,22.22,54.76,CuT-AsthMa: Culturally tailored school-based intervention for asthma in Malaysia,47.62,HUB > BREATHE,1.1.7,009bcb87-05f3-46e6-8866-7e4df698cb19,0692d86c-1f24-43a4-9508-005d00bd7259,Not Rated,66.91
69.84,20.93,Bronze,20.63,69.05,HCV Research UK,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,01492322-9b33-41cc-9f51-484024e45878,069c213c-eb04-463e-a300-7614c03cf623,Bronze,74.06
86.5,25.58,Silver,25.4,92.86,"OMOP dataset: Hospital COVID patients: severity, acuity, therapies, outcomes",98.41,HUB > PIONEER,1.1.7,0eb789bb-0047-46ac-83ff-631f31e98da0,06dee089-8c10-4a8b-aa94-7cb699dc3c80,Gold,83.64
37.3,39.53,Not Rated,39.68,16.67,Millennium Clinical Events,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,5f45bcd1-970b-44ba-8ae2-0fb49b85ffa9,0711cc7e-80d5-4781-a1ab-2637ea176ceb,Not Rated,38.57
76.98,16.28,Silver,17.46,80.95,Prospective Observation of Fibrosis in the Lung Clinical Endpoints,71.43,HUB > BREATHE,1.1.7,bb8de9d2-cc38-4c40-b104-ffd167f64f76,0715a950-3999-46d8-a646-6496866638a1,Silver,82.34
51.59,30.23,Not Rated,28.57,33.33,Exome sequencing,31.75,UK Biobank,1.1.7,2ddf0659-f05a-4f1c-b558-63a96e5b49f7,07b82dd5-adc3-42c5-8a60-914042b5bc40,Not Rated,51.55
78.57,27.91,Bronze,26.98,76.19,The impact of COVID on hospitalised patients with COPD; a dataset in OMOP,84.13,HUB > PIONEER,1.1.7,323dc330-aad9-472a-b579-ab66f5f75906,07e3ac82-a38d-45f3-9933-07439f6a761d,Silver,74.14
80.95,25.58,Silver,26.98,80.95,Careers Wales dataset,88.89,ALLIANCE > SAIL,1.1.7,e4004e0e-6adb-4b11-82c2-af0caf61d751,08846261-45f0-4bcf-9801-fe785dcef1c9,Silver,77.69
40.48,37.21,Not Rated,36.51,21.43,Walker Study Data,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,245bffa9-07c3-40b6-916b-161062cdf674,08a29778-afac-4ae0-86fc-5ca544d53874,Not Rated,42.11
43.65,34.88,Not Rated,36.51,28.57,Labour Force Survey (Household),23.81,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,0b630200-1e7c-4b19-ad53-bcc8863f7ade,08fd6103-be40-4380-9399-aecaeb216d33,Not Rated,46.84
77.78,27.91,Bronze,26.98,73.81,The acute presentation of pregnant women to non-maternity Emergency departments,82.54,HUB > PIONEER,1.1.7,86632207-1e57-4272-b178-ea069a13cae1,0942304f-8b91-4258-af9c-3a1801c7e79f,Silver,72.95
43.65,32.56,Not Rated,34.92,26.19,Paediatric Intensive Care Audit Network - customised data collection,22.22,ALLIANCE > HQIP,1.1.7,6c78af2c-3898-435e-b1f4-e6a44682dc71,09586db0-4da4-47f8-9434-13cbd2da2bb9,Not Rated,46.81
69.84,20.93,Bronze,20.63,69.05,ICON9 Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,1fdf266c-d5d8-418d-a423-81265da540a2,097cc6bd-ce98-47ec-a73d-5d2c250f2697,Bronze,74.06
68.25,18.6,Bronze,20.63,66.67,Development of spirometry predictive values for Indian population,57.14,HUB > BREATHE,1.1.7,59521b01-6adb-4dd3-8b40-dbeb51171e4f,0985f58b-87e0-42d2-9ee7-efd618abcd51,Bronze,74.03
73.02,13.95,Silver,15.87,69.05,National Records of Scotland (NRS) - Births Data,61.9,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,3b87eef0-bfb6-4bf4-84b9-29880197fec9,09d6c72a-7d11-4116-8cf8-6b0da9724bd0,Bronze,77.55
69.84,16.28,Silver,19.05,69.05,Reasons for delay in seeking care for pneumonia in children under five,58.73,HUB > BREATHE,1.1.7,46f50b9b-b8e2-4ff1-a1b3-779174c3d032,09e8e407-82b4-4ed4-b296-53810472cbe9,Bronze,76.38
43.65,32.56,Not Rated,34.92,26.19,Paediatric Intensive Care Audit Network - core dataset (transport),22.22,ALLIANCE > HQIP,1.1.7,45310176-6331-4bdd-bc53-d9194e212a35,0a418d30-c13c-404a-9f4c-39334d889b9c,Not Rated,46.81
68.25,23.26,Bronze,23.81,69.05,HPB Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,ebe6c9dd-fb95-4301-a929-c21b8077753a,0b7ea326-fc05-4aca-a962-3f93128b91d1,Bronze,72.89
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - clinical audit,22.22,ALLIANCE > HQIP,1.1.7,3afbb83d-d47b-43b3-a202-0d3081e5d294,0bb202c7-80e8-4532-8042-1351576e6c94,Not Rated,45.66
68.25,23.26,Bronze,23.81,69.05,Tissue Access for Patient Benefit (TAPb),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,35985f8e-f01a-41cc-a9e2-30299d3d6eed,0c50801d-1079-4879-b608-5e8f112b313f,Bronze,72.89
40.48,37.21,Not Rated,36.51,21.43,Fife Microbiology: Isolations,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,79086e92-cbbf-4615-b642-bc65d8a3bc6d,0c74238f-58b4-42d4-a97a-94737d75a897,Not Rated,42.11
54.76,39.53,Not Rated,36.51,47.62,Mental Health Services Data Set - Community,46.03,ALLIANCE > NHS DIGITAL,1.1.7,f3bb6a68-2c32-40a7-9a79-61a718068893,0c98200b-48b5-418a-b8d0-a7708abc1f39,Not Rated,54.05
86.51,18.6,Silver,20.63,88.1,Prescribing Information System (PIS),93.65,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,22e3943e-edb5-44a1-9e4e-22b0f7a31767,0cb92a4a-cc82-4c33-98f7-06ba93818c50,Gold,84.75
68.25,18.6,Bronze,20.63,66.67,Research on use of an online learning platform on under-five pneumonia,57.14,HUB > BREATHE,1.1.7,a3d85fd2-9df3-4f6e-9035-0830a3488ddb,0d0ce21e-afc1-4d9f-bf54-e0545363a0cc,Bronze,74.03
69.05,39.53,Bronze,42.86,73.81,Mental Health Services Data Set,80.95,ALLIANCE > NHS DIGITAL,1.1.7,fa2ec63d-f76d-4555-8fc1-f4bd66e3c60d,0d5bb5b4-ad38-4313-8b19-cd37491c0b41,Bronze,67.14
71.43,20.93,Bronze,20.63,71.43,The Cleft Collective,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,12288034-00a4-47a8-a779-1cf7a55270e4,0d6ab9af-c43b-490d-b39c-2d72de46a661,Bronze,75.25
69.84,20.93,Bronze,20.63,69.05,MRC Brain Banks Network,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,6f1b9a4e-2367-47f1-a985-3ed9bf3a7211,0d70b5c8-da5d-49c5-8ff5-0bdc7b5f6306,Bronze,74.06
69.84,20.93,Bronze,20.63,69.05,Leeds NIHR Biomarker Research Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,8648d251-6186-4383-82fc-c036a87c3842,0d79e0d8-9b3d-4450-9c34-0539673dc9a5,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Neonatal Audit Programme - clinical audit,22.22,ALLIANCE > HQIP,1.1.7,382e897a-77cf-46ca-8d44-d79449ab61df,0d89c503-1c79-4e2a-baf6-02f12e68805b,Not Rated,47.98
72.22,34.88,Bronze,34.92,73.81,Real Time Data Network (RTDN),79.37,HUB > DATA-CAN,1.1.7,616c4488-65a5-4608-a187-0c6bc78b359a,0ddcb454-2372-4180-9ba0-a7e1896d4fe2,Bronze,69.47
73.02,32.56,Bronze,33.33,71.43,Cancer Registration Data,79.37,ALLIANCE > NHS DIGITAL,1.1.7,2ed7bbbc-80db-46c2-a45b-632dda40794b,0e07413c-892c-4f06-bd22-2a917eb5c905,Bronze,69.44
69.84,39.53,Not Rated,39.68,71.43,HES Accident and Emergency data for CPRD Aurum,79.37,ALLIANCE > CPRD,1.1.7,c43501ec-08b4-4d33-a7dd-d19fca821925,0e59698c-1532-4155-ab0e-af11b3d9e7b1,Bronze,65.95
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Sensitive) Episodes,77.78,ALLIANCE > NHS DIGITAL,1.1.7,29c61f09-c4a1-425f-9bbc-888c23d99516,0e6e6ed5-ab81-4d7f-b06a-768bf33357ca,Not Rated,56.57
40.48,37.21,Not Rated,36.51,21.43,Tayside Bowel Screening Dataset,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,00201dde-1faf-41d3-b282-5c24c0ca3697,0e80170d-de4f-4349-a879-c54a70262736,Not Rated,42.11
62.7,20.93,Bronze,22.22,54.76,Developing and Evaluating Interventions to Improve Asthma Care,47.62,HUB > BREATHE,1.1.7,d57d7956-d13e-49c4-bb31-889b8e560596,0e8546e9-c841-4a99-a3f8-bb9020c6782c,Not Rated,66.91
69.84,20.93,Bronze,20.63,69.05,Cardamon Clinical Trial Samples,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,c0dcceca-c8cf-4269-a0e0-0c18b6ba2de1,0ecedaa2-e8f5-4eb2-ad3f-fc2ce433fc36,Bronze,74.06
69.84,20.93,Bronze,20.63,69.05,UKALL14 Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,b5533cb5-0c59-495b-9b11-3c401daeb958,0faa4c3e-edf5-4ae8-9b26-c59c98e26b57,Bronze,74.06
58.73,46.51,Not Rated,42.86,47.62,National Radiotherapy Dataset (RTDS) for CPRD Aurum,60.32,ALLIANCE > CPRD,1.1.7,9c535c8d-ebac-4212-b602-fc2489df2c92,0fbd11c2-c44b-430f-b527-63cb82fcee63,Not Rated,50.55
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,9c8bd383-b117-4167-a25c-9e15fa5ec1c6,0fc61ace-397d-4489-9e62-77f88082e775,Not Rated,56.57
85.72,23.26,Silver,23.81,90.48,IBD NIHR BioResource: Health and Lifestyle Questionnaire,95.24,HUB > GUT REACTION,1.1.7,18bfe765-5733-41f3-8114-0a1ec2524b5b,1046b837-c4d9-4688-a06e-d7b32d37a161,Silver,83.61
38.89,39.53,Not Rated,39.68,21.43,CDE Patient Demographics,17.46,ALLIANCE > BARTS HEALTH,1.1.7,209d7fae-0521-4d07-8a4d-e0843a46a107,10b10bc5-ce28-4cc0-b006-2a0e6d03a72d,Not Rated,40.95
45.23,30.23,Not Rated,31.75,26.19,National Audit of Dementia Round 4 - carer experience survey,22.22,ALLIANCE > HQIP,1.1.7,3b5907da-256d-49a3-b24b-00893afe8bdd,11571357-b9fc-45ed-ab40-3bb3d7443245,Not Rated,47.98
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry Audit Carotid Lower Limb Amputation clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,03e77b9d-57b8-44d5-8d64-9b1325958b22,12690263-f5d3-435b-9582-de1a88064e1e,Not Rated,47.98
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Revision Hip Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,4b8286e2-c4e4-4db4-8fd9-5f1c8b4e56de,12c5b83c-6e4a-442e-b6c2-2f6b7165fe6b,Not Rated,47.98
69.05,23.26,Bronze,22.22,69.05,UK primary Sjogren's syndrome Registry,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,38fe1a10-ebf9-4dc1-8c35-2e7b33b1f6b5,12dba445-dfa9-46af-abc0-5bd3701061a7,Bronze,72.89
69.05,23.26,Bronze,22.22,69.05,Manchester Eye Tissue Repository,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,47fc8f03-eba1-4efa-ae3e-148a76b56517,1406c52a-e5d6-4c57-883d-62e405eb604a,Bronze,72.89
43.65,32.56,Not Rated,34.92,26.19,Paediatric Intensive Care Audit Network - core dataset (referral),22.22,ALLIANCE > HQIP,1.1.7,79ae4881-6223-471a-a278-6b2d3b84f971,148a3896-e4ed-48ef-8643-48df726041e1,Not Rated,46.81
82.54,25.58,Silver,34.92,95.24,Cystic Fibrosis Patient Sweat Tests,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,34f0c2bd-d42e-4441-a89b-e0e384f12afa,148ebbaa-28f4-42e0-a27f-8587e516c3bf,Silver,84.83
76.98,32.56,Bronze,33.33,80.95,MSDS (Maternity Services Data Set),87.3,ALLIANCE > NHS DIGITAL,1.1.7,11d3cf0f-ae5d-42f4-a756-b98c3eff46bc,15123705-7d80-4803-a3b4-d145bf2902c5,Silver,74.19
87.3,20.93,Gold,25.4,95.24,Active Adult Survey,100.0,ALLIANCE > SAIL,1.1.7,1eb67fd5-33f6-49dd-a43d-854fff9f25f5,15805559-2115-4822-b91f-635de36fb289,Gold,87.16
77.78,30.23,Bronze,33.33,80.95,UHB 2020 Winter Society of Acute Medicine Benchmarking Audit,88.89,HUB > PIONEER,1.1.7,5bf9bf39-3cd7-4a54-994b-9914405f945e,1584af1e-9683-4727-8c9b-9bea8beaa68d,Silver,75.36
87.3,25.58,Silver,25.4,95.24,GENOMICS ENGLAND 100K QUICK VIEW,100.0,GENOMICS ENGLAND,1.1.7,4cc5ed33-3190-4f80-953b-cabd5a2b1c7c,15efea36-d022-495c-a5b6-90f51631a643,Gold,84.83
71.43,20.93,Bronze,20.63,71.43,MFT Biobank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,d17efe5d-325f-4fcf-b25e-87d1f6269bea,16445ebd-bd45-4ded-a7ae-05f33f676598,Bronze,75.25
71.43,13.95,Bronze,14.29,64.29,Child Health Systems Programme - School,57.14,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,2c31cb1c-2b3d-40c5-b8d4-bf0b81f089b4,164bf6c1-79f2-4ada-98f6-85b7113d4d20,Bronze,75.17
69.84,20.93,Bronze,20.63,69.05,Cambridge Blood and Stem Cell Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,c51ab59a-33ce-4145-a642-7f3f96bca545,167cc04b-23b8-4a9e-9ff9-6c8e07d6a561,Bronze,74.06
75.39,30.23,Bronze,34.92,78.57,NHS 111 Dataset,85.71,ALLIANCE > SAIL,1.1.7,3d6b69dc-cb3c-4b9a-bdea-a798e7d5b5cf,16e343ce-61f5-4f04-9fae-4fa6c9babf61,Bronze,74.17
37.3,39.53,Not Rated,39.68,16.67,ARIA Medonc,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,88eb839c-bc51-45f0-b15e-ea89bba9ffca,172242ce-a1c5-4915-9c71-686f6e7d5789,Not Rated,38.57
76.99,27.91,Bronze,28.57,76.19,COVID-19 research: Master Dataset,82.54,ALLIANCE > BARTS HEALTH,1.1.7,ec4a0913-dffd-4fad-9889-656ca7f058d0,172287c8-05fd-4754-a405-3c18745b73ea,Silver,74.14
77.78,30.23,Bronze,33.33,80.95,UHB 2019 Summer Society of Acute Medicine Benchmarking Audit,88.89,HUB > PIONEER,1.1.7,5acfadf9-21a7-4517-a1b2-620d20469611,1785cc1a-ace0-4980-8352-5977b2b72969,Silver,75.36
69.05,23.26,Bronze,22.22,69.05,IoN Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,e10a660d-b84c-475f-abd4-024dd1af7a5d,17cd75a2-e2b5-440c-89b1-22c9f3b03a03,Bronze,72.89
59.52,25.58,Not Rated,25.4,52.38,Generation Scotland: Scottish Family Health Study,44.44,ALLIANCE > GENERATION SCOTLAND,1.1.7,f4f0ef1a-46cf-4734-8516-3adb0b62ae6d,17ff9515-8296-435b-a50e-014168714689,Not Rated,63.4
80.16,25.58,Silver,25.4,78.57,Personal Demographic Service,85.71,ALLIANCE > NHS DIGITAL,1.1.7,f8be6d46-61de-4ed3-b127-76cdf92209d0,18028eac-b157-4264-9b86-9928c8e1709a,Silver,76.5
60.31,46.51,Not Rated,42.86,50.0,Rural-Urban classification for CPRD GOLD,63.49,ALLIANCE > CPRD,1.1.7,a7d8c6a8-0825-4e73-8f29-3d76194d7114,1841e7c9-39e1-4eff-9d2f-da3dede71f86,Not Rated,51.75
69.05,16.28,Bronze,19.05,66.67,Asthma and COPD: practices and perceptions of GPs in rural India,57.14,HUB > BREATHE,1.1.7,c15bc3ad-c053-496b-863f-1d54075d5bd4,184b973d-ac38-4fc5-8203-f2a244574b4f,Bronze,75.19
44.45,32.56,Not Rated,33.33,26.19,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - case note audit,22.22,ALLIANCE > HQIP,1.1.7,24b88d1a-4363-4619-870e-9ba9fc5d09e1,18603ae7-a056-4fd6-a3e5-d32a2440dd26,Not Rated,46.81
86.51,23.26,Silver,26.98,95.24,GENOMICS ENGLAND 100K BIOINFORMATICS DATA,100.0,ALLIANCE > GENOMICS ENGLAND,1.1.7,98999c67-0133-4f11-be95-b84ee5727c84,1900af1a-bd21-4157-ac48-203eec682073,Gold,85.99
69.05,18.6,Silver,20.63,71.43,Early Pandemic Evaluation and Enhanced Surveillance of COVID-19 (EAVE II),58.73,HUB > BREATHE,1.1.7,25bc9862-5b6c-4dda-80b2-46642d9e518a,191c1e3f-4eff-41b9-bff1-c6510f7c6c3d,Bronze,76.42
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): COPD secondary care clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,85b4dc84-88f4-4740-80fa-fa1eb04a0ae6,1a0af437-ec80-4db7-9c76-a2418cc8c5c8,Not Rated,45.66
71.43,20.93,Bronze,20.63,71.43,UK real-world lymphoid tissue bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,c9f82f86-79e1-4067-932f-5e6dc939006d,1a412ff0-6275-4cab-a485-bb76befc7afe,Bronze,75.25
82.54,25.58,Silver,34.92,95.24,Cystic Fibrosis Patient CFQ-R,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,9cf5dbd3-a109-4e8d-b1bb-7e4126bd887f,1a4b65e9-5241-4081-9cbb-43a8c8c6ea3b,Silver,84.83
61.91,20.93,Not Rated,22.22,52.38,Air Quality Study: An ecological analysis of asthma health outcomes in Malaysia,46.03,HUB > BREATHE,1.1.7,95f385b1-4f5c-4a88-8e79-9613acc66938,1b80d25c-4f0f-497b-8614-4d1a8c4d1cd3,Not Rated,65.72
73.02,34.88,Bronze,38.1,76.19,Linked Census and death occurrences,84.13,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,54095c0e-6faa-4de4-ac26-e2c7ef3cba5c,1bfdab55-3e6a-4b26-bff1-0105ad416cea,Bronze,70.66
75.4,27.91,Bronze,31.75,76.19,COVID-19 Test Trace and Protect [CTTP],82.54,ALLIANCE > SAIL,1.1.7,c0fc84af-aeab-4c7e-aa0b-8264baff55d9,1c1ada6a-d6e4-4415-a291-81f21acf8f81,Bronze,74.14
78.57,27.91,Bronze,28.57,78.57,NIHR BioResource: Health and Lifestyle Questionnaire,85.71,ALLIANCE > NIHR BIORESOURCE,1.1.7,321e3ad6-96b9-4f19-bbc4-d06dfe2a59d5,1c3f55ec-d6fc-477e-a1b7-4b8dd43323c6,Silver,75.33
54.76,39.53,Not Rated,36.51,47.62,Mental Health Services Data Set - Service Users,46.03,ALLIANCE > NHS DIGITAL,1.1.7,f48ad0a1-f90c-4a81-8c04-b23f2d8baf7a,1d5e3b05-8ce3-4f80-ae3a-f6031ad8cf69,Not Rated,54.05
42.86,34.88,Not Rated,36.51,26.19,National Cardiac Audit Programme - National Audit of Percutaneous Coronary Interventions (PCI),22.22,ALLIANCE > HQIP,1.1.7,ac7016ce-f7a9-4c71-bebb-6af6efa27844,1da704e3-f5ee-4614-8880-10541637a0b7,Not Rated,45.66
40.48,37.21,Not Rated,36.51,21.43,Patient SIMD Postcode,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,798567eb-d790-466e-880b-75a1e94ffdf2,1db7ce43-0dc3-4fa9-8bc8-14db16aba508,Not Rated,42.11
37.3,41.86,Not Rated,41.27,19.05,Somerset Cancer Registry,15.87,ALLIANCE > BARTS HEALTH,1.1.7,3ec5f1c4-95c0-4b1d-899b-399cec32ad49,1e465797-5e54-4667-9120-d373e75be64f,Not Rated,38.59
67.46,23.26,Bronze,23.81,66.67,NIHR BioResource: SNP imputation data,58.73,ALLIANCE > NIHR BIORESOURCE,1.1.7,39d7ad29-be30-4e12-a7c8-d8757141de85,1fcbb814-10e0-43b7-b383-b5c818090ac8,Bronze,71.7
88.89,20.93,Gold,22.22,95.24,Patient Episode Dataset for Wales,100.0,ALLIANCE > SAIL,1.1.7,4c33a5d2-164c-41d7-9797-dc2b008cc852,2057a9e3-b491-4d8f-874c-9857d00116b0,Gold,87.16
83.34,27.91,Silver,30.16,92.86,Moorfields Eye Image Dataset Release 001,96.83,HUB > INSIGHT,1.1.7,6bfe44ef-9532-4986-b8a2-9c2cda4a89cc,208f79dc-2294-4370-8f16-0d0f7bec9d10,Silver,82.47
65.08,41.86,Bronze,41.27,80.95,South London and Maudsley NHS Foundation Trust (SLaM) Clinical Record Interactive Search (CRIS) platform,71.43,ALLIANCE > SLaM,1.1.7,a25a9892-9141-4e78-8415-945ba73da11e,21cd4b8e-f4f5-44a6-83eb-b7799e98ba55,Not Rated,69.55
80.96,25.58,Silver,28.57,83.33,Scotland Accident and Emergency,90.48,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,05e6752e-3a0b-4809-aa14-207b4761ef60,22173c55-25db-4616-97d8-04fdb6899387,Silver,78.88
71.43,20.93,Bronze,20.63,71.43,QTL Programme at MRC HGU,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,351cc017-caff-4303-8a48-1aa1b90fce2b,22739526-317f-4b0e-a23b-ece0c859958f,Bronze,75.25
69.84,20.93,Bronze,20.63,69.05,Children's Cancer and Leukaemia Group (CCLG) Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,c232fa07-5d28-4bdc-b540-1ad8d933c5f9,227fe0ea-d76e-4c14-a33e-ca255380937d,Bronze,74.06
69.84,20.93,Bronze,20.63,69.05,University of Liverpool - GCP Laboratory Facility,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,029b7f0f-911e-46ce-837f-031959f067da,22974866-44c7-4176-9c51-6b57a1dda39d,Bronze,74.06
87.3,23.26,Silver,25.4,95.24,COG-UK Viral Genome Sequences,100.0,ALLIANCE > COVID-19 GENOMICS UK,1.1.7,1fe02b65-7b77-43bf-93c8-4f0743fee672,22e67d6b-3c86-46bc-8472-97ebe70773fa,Gold,85.99
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Revision Knee Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,6664317b-39b9-4133-b6c7-ec4bddf78c76,23330792-fe18-4331-a101-b246657a03ae,Not Rated,47.98
42.86,34.88,Not Rated,36.51,26.19,Falls and Fragility Fracture Audit Programme Fracture Liaison Service Database clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,d94a604c-5733-4f07-93bb-e77b6ea2313f,237e724d-03b2-478c-a92d-85a1baa6ae53,Not Rated,45.66
82.54,30.23,Silver,34.92,95.24,GENOMICS ENGLAND 100K RARE DISEASE & COMMON,100.0,GENOMICS ENGLAND,1.1.7,3f2b37f1-e8f7-42e5-83c4-fc9e1c58725d,239e8253-a997-4676-8940-16b74a004365,Silver,82.5
79.37,11.63,Silver,12.7,80.95,Idiopathic Pulmonary Fibrosis (IPF) Genome-wide Association Study,71.43,HUB > BREATHE,1.1.7,b850e56c-5c5b-413e-b829-743772053978,24b82645-1854-438a-97b2-911bba469d3d,Silver,84.66
69.05,23.26,Bronze,22.22,69.05,SWIFT-RTB,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,d387ed7c-14fa-49e2-8ced-df0f9372eb88,24f2374a-e804-434e-a805-e29b332b0693,Bronze,72.89
82.54,25.58,Silver,25.4,83.33,General Acute Inpatient and Day Case - Scottish Morbidity Record (SMR01),90.48,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,98cda353-0011-45b2-80ca-4ed24cd084bf,2537007c-9e9e-4441-a0d1-59fa400566c5,Silver,78.88
69.05,16.28,Bronze,19.05,66.67,mHealth for pneumonia prevention,57.14,HUB > BREATHE,1.1.7,fc66381e-cc46-4bca-85fc-fc2ee09cc5dd,2542abf8-e50b-4962-9fa1-6dba1b7e8439,Bronze,75.19
89.69,18.6,Gold,20.63,95.24,Maternity Indicators Dataset,100.0,ALLIANCE > SAIL,1.1.7,a0c27454-8cbe-418f-bdae-a85d5e92e9d4,258c9577-76cd-45c7-a6b5-8e7eed07ce9e,Gold,88.32
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Non-Sensitive) Episodes,77.78,ALLIANCE > NHS DIGITAL,1.1.7,2964d1b0-2630-468a-82c1-00f5ac901b3d,263ad0a8-ae90-4c1d-85d6-c3d2470eb2b7,Not Rated,56.57
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v2.6 (Sensitive),77.78,ALLIANCE > NHS DIGITAL,1.1.7,dc37fcd6-1e68-46e5-b73d-4896e069746a,263f28a4-9835-4856-b1c3-0a0d4085f207,Not Rated,56.57
72.22,20.93,Silver,20.63,73.81,Arden Tissue Bank,65.08,ALLIANCE > TISSUE DIRECTORY,1.1.7,62fdfd1c-f195-49cc-b3a1-7d9fd2cc8e1b,263f4ce3-7ccf-45c3-9d41-c1f5ed14cc81,Bronze,76.44
89.69,18.6,Gold,20.63,95.24,Welsh Cancer Intelligence and Surveillance Unit (WCISU),100.0,ALLIANCE > SAIL,1.1.7,368ad790-3ad8-4f93-9a7c-0bfb64dc6015,265cb00e-1731-4370-b748-203d8bd6c416,Gold,88.32
81.75,18.6,Silver,19.05,76.19,Child Health Systems Programme - 27-30Months Review,82.54,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,d2d57b7f-95d8-425f-b2fd-cc9aff05e659,26b03931-18ce-4a83-99de-1fca258518f3,Silver,78.8
87.3,20.93,Gold,25.4,95.24,Pathology Data from WRRS,100.0,ALLIANCE > SAIL,1.1.7,48ef8f54-9606-4e6f-9256-3cc07ffd10b8,26da4493-a78b-4090-ba18-e6c600d2c375,Gold,87.16
72.22,23.26,Silver,22.22,76.19,Scottish Human Papillomavirus Archive,66.67,ALLIANCE > TISSUE DIRECTORY,1.1.7,4883530f-1c8d-49aa-886e-ea3b958772ea,270b55a8-a9ee-44ee-8db6-eb214e721eea,Bronze,76.47
79.36,27.91,Bronze,26.98,78.57,"Deeply phenotyped sepsis patients within hospital: onset, treatments & outcomes",85.71,HUB > PIONEER,1.1.7,38ff49e2-dffa-4103-87a8-386f9f424d22,273e091c-d0b3-4529-9cd2-4bc1a1b6195a,Silver,75.33
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (clinical),22.22,ALLIANCE > HQIP,1.1.7,33b36393-3760-40d8-bb98-61806fea5398,278c3fb2-6b1e-46db-a529-9fc7ddaf4461,Not Rated,45.66
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,7c2b435c-5442-4a05-9b8d-08024ec57c30,2a725f9d-c4a9-4c89-aa37-b3c25cc83389,Not Rated,56.57
74.6,32.56,Bronze,31.75,73.81,Admissions & Discharges,80.95,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,1.1.7,1d5b9205-dae4-4b0e-a3d3-04707875edf8,2aabcea9-d0dd-4780-b162-3c7ed3ee9888,Bronze,70.62
40.48,37.21,Not Rated,36.51,21.43,Renal Register – ISD National dataset,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,32edd77d-533c-423f-b045-937507f8505d,2ab363bf-3013-475b-8254-bd7740f70edb,Not Rated,42.11
85.72,23.26,Silver,26.98,92.86,Millennium Cohort Study,98.41,ALLIANCE > SAIL,1.1.7,a380bd6b-009f-4b78-b638-ba9ee62be2eb,2b09ea87-5b22-4049-b7dd-de0889699115,Silver,84.8
76.98,32.56,Bronze,31.75,78.57,Leeds-IQVIA Collaboration,85.71,HUB > DATA-CAN,1.1.7,00b897c7-d50d-486a-af1b-bd94821b58f7,2b40a784-79ea-4403-a4bd-0950a7a36a6c,Silver,73.0
69.05,25.58,Bronze,25.4,71.43,UCL Infection DNA Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,3e5fb54a-84ec-4888-9a72-4093c6e90dbc,2bd45ffb-b22f-4f02-968b-f5ab8f9d6342,Bronze,72.93
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Revision Ankle Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,b4f076d2-c9a3-49ba-84f4-94148dc8511a,2c0e04bc-2f16-4903-90dc-c9d57ab40efb,Not Rated,47.98
69.84,20.93,Bronze,20.63,69.05,MDSBio,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,13c71637-144e-4742-8aea-aefb778a360e,2c3e75c3-141a-4d29-b7f0-0dbe14fb18fd,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Diabetes Inpatient Audit Hospital Characteristics Survey dataset,22.22,ALLIANCE > HQIP,1.1.7,a9098b51-f8ec-432e-a52f-f4c1f2c1e4f6,2c53d1f7-4540-4c57-8e93-8115b8abc6a9,Not Rated,47.98
60.31,46.51,Not Rated,42.86,50.0,Rural-Urban classification for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,b7d24b82-f8a4-4838-844c-ecd86ddf5db2,2d23ad3c-0541-453c-8bf7-9dc42e1aba65,Not Rated,51.75
59.53,48.84,Not Rated,44.44,50.0,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,3a387099-e69e-479d-a937-2cc3795d7170,2d3302d1-b6fc-4883-8168-010da0d48638,Not Rated,50.58
84.92,27.91,Silver,30.16,95.24,GENOMICS ENGLAND 100K NHSD LINKED DATA,100.0,GENOMICS ENGLAND,1.1.7,14c31b39-f189-4417-bd38-635268495593,2d4b933d-1c8b-4fde-860e-c324454d28f9,Silver,83.66
61.91,23.26,Bronze,23.81,57.14,IBD NIHR BioResource: NHS Trust data,47.62,HUB > GUT REACTION,1.1.7,ae1898da-7fe5-4fe0-b10d-9f06cdec1735,2d6e8e68-2fc9-4b9c-a517-c5c5677af225,Not Rated,66.94
42.86,34.88,Not Rated,36.51,26.19,Falls and Fragility Fracture Audit Programme National Hip Database Facilities Survey 2019,22.22,ALLIANCE > HQIP,1.1.7,025c9e8a-938b-4886-9e03-fcad90fe7157,2dbd2e38-a4bb-4f8c-b401-ebec10f0d89e,Not Rated,45.66
65.08,20.93,Bronze,22.22,59.52,"4 Country ChrOnic: estimating respiratory disease burden in adults, South India",52.38,HUB > BREATHE,1.1.7,2f1244b8-7cbf-4fa3-8534-433efd769d48,2dc79612-0e0d-4336-aaa1-6abd90d28589,Not Rated,69.3
55.55,51.16,Not Rated,52.38,50.0,Mental Health Dataset (MHDS) for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,48627b2d-f247-4921-9ee1-6c37adfff10d,2e8cc70b-bd57-4b64-bd12-fbc07e0f240f,Not Rated,49.42
45.23,30.23,Not Rated,31.75,26.19,National Audit of Dementia Round 4 - casenote audit,22.22,ALLIANCE > HQIP,1.1.7,587a94e6-48a4-4e5e-8230-4018897bc7c7,304430ff-0aff-4d36-91e5-94be251a409a,Not Rated,47.98
69.84,20.93,Bronze,20.63,69.05,Watch and Wait Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,e46dccbf-484d-45d2-a42a-4d308b87c113,30a0ee0e-d9f9-4341-b00c-2fab8f122b5f,Bronze,74.06
76.98,30.23,Bronze,33.33,78.57,Systemic Anti-Cancer Therapy Dataset [SACT],87.3,ALLIANCE > SAIL,1.1.7,6c4ed998-0f05-415c-a3e4-42430bb62d24,3141f405-9653-4189-9a1f-443a463d4b1b,Silver,74.17
86.51,23.26,Silver,26.98,95.24,Wales Asthma Observatory,100.0,HUB > BREATHE,1.1.7,8604bcdc-235a-4c70-b29b-1617396815e6,333d92ca-3a32-41bd-8b16-96aee2dc85b1,Gold,85.99
69.05,23.26,Bronze,22.22,69.05,TRICON8B,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,ff875c08-58e6-4e33-8ffe-6f51c8364333,33e4b8c6-23cc-4c5f-a7a5-8380035b6601,Bronze,72.89
40.48,37.21,Not Rated,36.51,21.43,"Deaths – CHI, Community Health Index",17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,faf2fc49-d09f-4ea2-a2cb-b1d30fffa406,33e96a6f-8791-48c7-a440-889dba594c36,Not Rated,42.11
76.19,34.88,Bronze,33.33,78.57,National Cancer TRE,85.71,HUB > DATA-CAN,1.1.7,b5439bc5-8141-4a13-a024-a6db2003b40e,34f9be53-2445-439b-8ca4-f151359d7e46,Silver,71.84
71.43,20.93,Bronze,20.63,71.43,BRAIN UK,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,1c455ad3-af51-4b93-aff4-c5d3dacfa9f4,359006d7-1c6c-43c2-8905-09b016398ae1,Bronze,75.25
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v3_3.5 (Sensitive),77.78,ALLIANCE > NHS DIGITAL,1.1.7,c123f74c-0731-428e-b31b-eee2723df54d,36047c5f-7d57-4d25-a114-2bcc6c11708f,Not Rated,56.57
40.48,37.21,Not Rated,36.51,21.43,NHS Tayside and Fife Accident & Emergency Dataset (ISD/National),17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,750063ea-6bfd-4492-9748-2a18080cf6ea,3728b674-68a2-4710-9f8e-b0fc3f2add10,Not Rated,42.11
71.43,20.93,Bronze,20.63,71.43,Bristol Dental School Saliva Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,8d77f0ad-f376-4d61-a97d-5e996c2bbe72,37687806-bab2-4de8-87a7-844a0061e7f8,Bronze,75.25
62.7,18.6,Bronze,20.63,52.38,Exploring psychological issues of primary care teams in Malaysia amidst COVID-19,46.03,HUB > BREATHE,1.1.7,64f78a5f-268f-4951-9c91-f7e7130baffa,37eb2884-d7df-489f-a3ad-f02f1e510475,Not Rated,66.89
71.43,20.93,Bronze,20.63,71.43,UK MND Collections,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,89e2d798-c488-4eaf-a50f-a93616093304,381413fe-8808-47f8-b8df-e65baa543ae4,Bronze,75.25
81.75,27.91,Silver,33.33,92.86,North West London Pathology (NWL PATH),96.83,HUB > DISCOVER NOW,1.1.7,2c5f3ef6-53f8-42e6-a077-8718261df026,38194ca7-57f5-40ff-b463-900e306cd40f,Silver,82.47
68.25,23.26,Bronze,23.81,69.05,NIHR Nottingham Digestive Diseases Collection,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,f20bf814-ee80-4e67-ab00-afff884ddbb4,38254214-35f1-4564-b7bb-aab331732dab,Bronze,72.89
70.63,39.53,Bronze,44.44,78.57,Civil Registration - Deaths,85.71,ALLIANCE > NHS DIGITAL,1.1.7,050163dc-1728-4ac5-a7d9-4dd3ca0ca12a,384176d1-8c17-46e5-8771-7e27fe3b184e,Bronze,69.52
89.69,18.6,Gold,20.63,95.24,Congenital Anomaly Register and Information Service,100.0,ALLIANCE > SAIL,1.1.7,6fe7e004-eb51-4c7b-9905-1ec9a4827dca,38468759-3351-4722-9eeb-4c6dc9fa44ce,Gold,88.32
79.36,27.91,Bronze,26.98,78.57,Clinical response thresholds (acuity) in acutely unwell patients: onset-outcome,85.71,HUB > PIONEER,1.1.7,a9018475-452b-4864-bbc3-80eda2067820,391ab58c-3412-4fa0-96f6-fdd5ae380b86,Silver,75.33
64.28,46.51,Not Rated,49.21,64.29,Bridge file: Hospital Episode Statistics to Diagnostic Imaging Dataset,77.78,ALLIANCE > NHS DIGITAL,1.1.7,2f73575d-23c8-4bb8-87db-115cde076127,3935e2fd-0c30-4f56-8388-45a02e0499b4,Not Rated,58.89
58.73,46.51,Not Rated,42.86,47.62,National Radiotherapy Dataset (RTDS) for CPRD GOLD,60.32,ALLIANCE > CPRD,1.1.7,56a66de8-3470-4a36-ac71-4d5471e72654,3943e6de-6c32-43dd-8090-16ec9ca0902f,Not Rated,50.55
43.65,32.56,Not Rated,34.92,26.19,National Cardiac Audit Programme - Cardiac Rhythm Management (CRM),22.22,ALLIANCE > HQIP,1.1.7,3cc81e6c-0c17-4ccd-8202-a9aceb82c989,395262e7-9846-4d9d-a288-8b0ebea782b9,Not Rated,46.81
45.23,30.23,Not Rated,31.75,26.19,Epilepsy 12 - clinical audit,22.22,ALLIANCE > HQIP,1.1.7,1fcaf429-8762-454c-b999-c5fdd757b880,3a51b861-026d-45ed-abe6-30d9cc07b516,Not Rated,47.98
56.35,27.91,Not Rated,25.4,42.86,Death register,38.1,UK Biobank,1.1.7,722056a5-5fc6-4ad2-8efe-62a80dd6389b,3a56c317-bf1b-448d-89ab-3421eae3aa18,Not Rated,57.48
42.86,34.88,Not Rated,36.51,26.19,National Paediatric Diabetes Audit - Spotlight survey of workforce in Paediatric Diabetes Units,22.22,ALLIANCE > HQIP,1.1.7,fe8f8e2c-2f77-464d-9d45-a601cb2f8bf9,3a9ab245-5fcc-49a0-ae58-12ebab9b0053,Not Rated,45.66
68.25,16.28,Bronze,19.05,64.29,COVID-19 Detection from Chest X-Rays using Deep Learning,55.56,HUB > BREATHE,1.1.7,57526718-0a9a-42ad-8b7a-582d9ef96d13,3aa01779-831e-478f-b4e3-7c111d642b18,Bronze,74.0
87.3,20.93,Gold,25.4,95.24,Annual District Birth Extract,100.0,ALLIANCE > SAIL,1.1.7,12a77014-4a77-4eb1-8b26-f49689352d1b,3ab70331-aa54-4f0d-aa95-ea2b95bed9d5,Gold,87.16
82.54,23.26,Silver,26.98,88.1,IBD NIHR BioResource: Consent records,92.06,HUB > GUT REACTION,1.1.7,44ca2cf8-679e-447c-a9eb-55b32159679a,3b0a3b33-dbd5-4cb0-b863-0e1fd80c9a1e,Silver,82.42
37.3,41.86,Not Rated,41.27,19.05,CDE Surginet Documentation,15.87,ALLIANCE > BARTS HEALTH,1.1.7,4c4bc482-16f5-462f-8daf-51ec6492074d,3b752633-8274-4418-b15b-4502bab03935,Not Rated,38.59
66.66,23.26,Bronze,23.81,64.29,IBD NIHR BioResource: SNP imputation data,57.14,HUB > GUT REACTION,1.1.7,7dee2bd6-733a-4b2e-a942-7f9eaf8ebbc2,3bb25cba-b4dc-47f1-ab5e-b63f89500612,Bronze,70.52
69.84,23.26,Bronze,22.22,71.43,Tissue Solutions Ltd,61.9,ALLIANCE > TISSUE DIRECTORY,1.1.7,bbcdc352-e0f7-4672-93a7-134bcf5001b1,3c23941a-42a7-4940-b32f-aea743c0dc2a,Bronze,74.09
73.02,30.23,Bronze,36.51,73.81,SICSAG Episodes (Scottish Intensive Care Audit Group),82.54,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,6f8182d2-2993-400d-829d-b52cdb324bf3,3c9e8226-f12c-4824-9996-29a667b9609c,Bronze,71.79
71.43,20.93,Bronze,20.63,71.43,TwinsUK,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,19b4cd38-3828-4bb1-a980-4f7420658965,3ce4870c-5062-4d01-8801-2cf505b979b7,Bronze,75.25
76.19,32.56,Bronze,33.33,78.57,Hospital Episode Statistics Accident and Emergency,85.71,ALLIANCE > NHS DIGITAL,1.1.7,3ddfccc3-ba32-4653-a999-966b8d6c412f,3ce8ddf2-c69b-4143-9e39-86c0ac2d8482,Silver,73.0
72.22,30.23,Bronze,34.92,73.81,Cancer Network Information System - CNIS / CANISC,79.37,ALLIANCE > SAIL,1.1.7,da91f0eb-1761-485b-8b7f-9121b6a1d004,3d13bc38-3f7f-4807-8847-2a10d6402dd3,Bronze,71.79
84.13,25.58,Silver,28.57,92.86,North West London Outpatient Care Data (NWL OP),96.83,HUB > DISCOVER NOW,1.1.7,9f1df859-f1d0-4f1e-959e-affd05138a25,3d51dc99-c44f-44ff-bdab-da205c5e394e,Silver,83.64
69.84,20.93,Bronze,20.63,69.05,Ethical Tissue - University of Bradford,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,fdf9ac68-fc89-4adf-9a73-3a94a9974aef,3db58c78-fc8b-49b2-a847-b43fd0184500,Bronze,74.06
50.0,44.19,Not Rated,46.03,35.71,Prescribing,46.03,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,6d044471-62d2-4190-b315-503f77d33ef2,3e13c6f0-2760-4ece-b047-77d750d9cdbd,Not Rated,45.76
44.45,32.56,Not Rated,33.33,26.19,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (patient experience survey),22.22,ALLIANCE > HQIP,1.1.7,d94eb31c-04c4-41b6-ad38-45f6aef30132,3e89692b-7aa2-49d6-b802-82921bd7e006,Not Rated,46.81
69.84,20.93,Bronze,20.63,69.05,Multiple Sclerosis and Parkinson's Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,4684d391-a6a7-44f7-bf4b-62b6b693f9fa,3f00330d-1f45-4cab-86c2-e91b7c1a59e9,Bronze,74.06
62.7,23.26,Bronze,23.81,59.52,NIHR BioResource: NHS Trust data,49.21,ALLIANCE > NIHR BIORESOURCE,1.1.7,3731006a-ee7c-4d15-bc07-4eeb29a3d031,3f1d93ae-792e-4f0c-8cb7-40413b81e132,Not Rated,68.13
43.65,32.56,Not Rated,34.92,26.19,National Emergency Laparotomy Audit - Patient Audit Dataset,22.22,ALLIANCE > HQIP,1.1.7,25b93812-191f-49bb-bbd0-782fb85b2bd2,3f299029-3126-4ce0-893c-4a759cbe90b1,Not Rated,46.81
75.39,30.23,Bronze,36.51,78.57,2011 Census variables (and variable breakdowns),87.3,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,a05aef07-c3fa-4331-905a-6b6f58eac3d5,3fb06d01-cde5-4e68-b438-cfa0b0f8de9a,Bronze,74.17
76.98,30.23,Bronze,31.75,78.57,The impact of ethnicity and multi-morbidity on C19 hospitalised outcomes,85.71,HUB > PIONEER,1.1.7,cfa1ef13-8ae0-4827-8a0f-9d2df5244725,3fc555e1-3e36-46dc-bef1-2d94d560bcb2,Silver,74.17
89.69,18.6,Gold,20.63,95.24,Cafcass Wales,100.0,ALLIANCE > SAIL,1.1.7,29a714e1-5289-4362-be24-2848c954344e,3fceb952-0b21-40f4-bd69-fa5cd7ad7df9,Gold,88.32
74.6,34.88,Bronze,34.92,76.19,Covid-19 UK Non-hospital Antigen Testing Results,84.13,ALLIANCE > NHS DIGITAL,1.1.7,f06ec631-77d0-4b12-a21f-f11e7af49ba5,401bfb5b-b66b-49e7-931a-280fd6694bbf,Bronze,70.66
37.3,39.53,Not Rated,39.68,16.67,Endobase,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,e830b2a5-14d6-4643-a206-619bf5372dc8,40573895-497b-4d47-90e1-6aafe70b93f6,Not Rated,38.57
73.81,34.88,Bronze,33.33,73.81,Secondary Uses Services Payment By Results,80.95,ALLIANCE > NHS DIGITAL,1.1.7,2004c512-f7c9-4995-b820-55f36aa3fad2,41369771-7b1d-478f-a96c-96c25b637cb2,Bronze,69.47
73.02,30.23,Bronze,31.75,71.43,Domiciliary Social Care Worker [DSCW],77.78,ALLIANCE > SAIL,1.1.7,0e38bbf4-c788-4a1a-9af8-a24821250154,41a667eb-1c84-4665-b0d4-d26405d277c5,Bronze,70.6
64.28,46.51,Not Rated,46.03,61.9,Mental Health and Learning Disabilities Data Set,74.6,ALLIANCE > NHS DIGITAL,1.1.7,e9b43936-e700-40c9-8b32-57ed44583f3d,4262e057-6978-4e4c-a05d-c4f328422090,Not Rated,57.7
73.81,16.28,Silver,17.46,71.43,Scottish Stillbirth and Infant Death Survey,65.08,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,e54d35a6-2e7c-422d-a4a5-a7da930b08f2,426c2cfb-3af8-444c-bfae-1b1f78c050ba,Bronze,77.58
45.23,30.23,Not Rated,31.75,26.19,National Neonatal Audit Programme - 2 year outcomes audit,22.22,ALLIANCE > HQIP,1.1.7,3bb02d77-9678-4e6e-832d-c2ed3ede412c,4271bc64-b139-40b0-98de-5f2e94e2d026,Not Rated,47.98
65.08,39.53,Not Rated,41.27,61.9,HES Patient Reported Outcomes Measures (PROMs) data for CPRD Aurum,71.43,ALLIANCE > CPRD,1.1.7,7958450d-bd25-42c4-b79e-0e3d0806ac21,42780b16-32e3-442e-92cd-1810bf30dab8,Not Rated,61.19
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Microbiology Cultures,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,9c1727f6-2032-413f-bf60-470769b2616e,42ac7c27-a37b-4081-8a33-51ac077e6a4e,Silver,83.66
42.86,34.88,Not Rated,36.51,26.19,Falls and Fragility Fracture Audit Programme National Audit of Inpatient Falls clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,3c19e2c9-96d5-45f3-9c55-fc3cec762cd7,430331ef-fa66-485b-b090-e4e83def9136,Not Rated,45.66
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,9c31a2bd-ff3a-4379-a4b8-0b90527a4c38,46493a09-b3bb-4c0e-b944-82665ee21508,Not Rated,56.57
70.63,32.56,Bronze,34.92,66.67,Census-Mortality-Hospital Episodes Linked Data,76.19,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,6064c3a9-e4f1-411b-8181-f1fdca2ab2b8,4661db47-82e6-4bc5-80a7-e7a1c3cc96b7,Bronze,67.06
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry - Organisational Audit dataset,22.22,ALLIANCE > HQIP,1.1.7,3c661240-e4d2-456c-a809-133c23f9c469,4678a81d-dfb6-478a-a373-d5510866b3d0,Not Rated,47.98
42.86,34.88,Not Rated,36.51,26.19,National Cardiac Audit Programme - National Congenital Heart Disease Audit (NCHDA),22.22,ALLIANCE > HQIP,1.1.7,2b640175-725a-465f-9aec-6794e6d27791,46e4c3ba-dae2-453d-832a-88ea603110f1,Not Rated,45.66
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry Audit - Lower Limb Bypass clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,d357be1e-27fe-4b2f-9174-3a2a03ecc12b,47bec08b-57b7-450e-9be7-af19bab99b58,Not Rated,47.98
69.84,20.93,Bronze,20.63,69.05,Tayside Biorepository,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,6ac9b356-00f1-49da-825a-6eb04d18e49d,47d22aea-cbe9-47d4-8f65-45861d9c5f6f,Bronze,74.06
66.67,18.6,Bronze,20.63,61.9,Theory of Planned Behaviour Intervention: respiratory disease in South India,53.97,HUB > BREATHE,1.1.7,7d23e729-72b0-4dd1-820d-07697b49acd0,47e9fa0a-d74f-43bc-ae63-0eb33f354f01,Bronze,71.65
69.84,25.58,Bronze,23.81,71.43,"St Thomas' Hospitals Plasma, serum & DNA Bio bank from patients with antiphospholipid antibodies",63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,425f4534-51c4-4f75-8ca0-d7c731dbd903,47f57de8-aa71-4df1-af4a-a81e37d4ae8c,Bronze,72.93
53.97,27.91,Not Rated,26.98,38.1,Genotype,34.92,UK Biobank,1.1.7,93a7352f-fce4-42c9-9a8c-efc7fe23eda0,480ccd8a-309e-417a-ac23-5b2d9cd281b1,Not Rated,55.09
84.13,25.58,Silver,28.57,92.86,North West London Primary Care Prescriptions Data (NWL PCP),96.83,HUB > DISCOVER NOW,1.1.7,0fb33df6-ab36-4170-9fad-1eaf35a3a812,48182af6-2ccd-44b2-92d5-69cc140e7d67,Silver,83.64
88.89,18.6,Gold,20.63,92.86,Daily Situation Report Data,98.41,ALLIANCE > SAIL,1.1.7,c74a9b9e-1fea-4aac-99fd-54e30668e085,4b6d3344-e73a-4f46-8e9d-fabb85827772,Gold,87.13
42.86,34.88,Not Rated,36.51,26.19,National Paediatric Diabetes Audit - Spotlight survey of diabetes-related technologies,22.22,ALLIANCE > HQIP,1.1.7,eecbdd8d-92a0-4dfd-a216-1cf7f1f8c98f,4b71fca4-8b2c-4e37-8996-b64a9c1450f0,Not Rated,45.66
69.84,20.93,Bronze,20.63,69.05,Obesity Research Biobank Syndicate (ORBiS),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,264a1987-a8cb-4a83-81e0-70b4c3893b7d,4cde083a-bf5a-4f57-97c6-38632e10050d,Bronze,74.06
69.84,20.93,Bronze,20.63,69.05,POUT-T,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,c6e0e70e-7f23-4a44-a2cf-1d7d87be7808,4dd3f23c-44be-4126-aac5-ba655d07855c,Bronze,74.06
63.49,23.26,Bronze,23.81,61.9,COPDMAP Consortium,50.79,HUB > BREATHE,1.1.7,bcbc41cb-99f7-482e-ba3d-561164abbd4e,505318b6-609c-4baf-9dea-2e3532f936f8,Not Rated,69.32
44.45,32.56,Not Rated,33.33,26.19,National Audit of Psychosis - Audit on Early Intervention in Psychosis services -  patient experience survey,22.22,ALLIANCE > HQIP,1.1.7,c3e63860-bd61-4154-ab5f-ca927fb029c4,50631db6-126e-4b3a-8035-444b66ba4afa,Not Rated,46.81
69.05,34.88,Bronze,42.86,73.81,RAPID (Hospital Stay Level Data),80.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,1fc57971-5af5-499e-a500-4ffbb087f0c4,50e341b3-11cb-4ea3-afd0-be193c0df91f,Bronze,69.47
37.3,39.53,Not Rated,39.68,16.67,Outpatient Appointment Dataset,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,1c27bfbf-c659-42ff-8afe-d58250b49c07,510e1782-1650-4342-9c20-185ca47f7b11,Not Rated,38.57
70.64,32.56,Bronze,39.68,76.19,Covid Vaccination Dataset (CVVD),80.95,ALLIANCE > SAIL,1.1.7,471f101c-a45e-4620-8710-be3036a46fba,511b96dd-3808-4131-9755-252944784f52,Bronze,71.81
76.19,30.23,Bronze,31.75,76.19,COVID-19 SARI-Watch (formerly CHESS),84.13,ALLIANCE > NHS DIGITAL,1.1.7,f61f116d-f732-450e-9d34-c6ae00e3fd1e,511f73b6-5181-408d-ae40-69b0ef70e732,Silver,72.98
37.3,41.86,Not Rated,41.27,19.05,ARIA Dataset,15.87,ALLIANCE > BARTS HEALTH,1.1.7,621dd611-adcf-4434-b538-eecdbe5f72cf,5271131b-ba5b-452d-b230-077094a031c2,Not Rated,38.59
73.8,32.56,Bronze,38.1,78.57,NIHR BioResource: SNP chip data,85.71,ALLIANCE > NIHR BIORESOURCE,1.1.7,c388676c-a5e5-419c-967c-239c1f0c3c5c,52a467b0-5401-4818-9c16-2e41d68704c1,Bronze,73.0
81.75,27.91,Silver,33.33,92.86,North West London Adult Social Care Data (NWL ASC),96.83,HUB > DISCOVER NOW,1.1.7,de9cf0f5-b26a-4363-9df8-3628a4aa6b6e,535a0983-6618-4211-a939-ae2edfe26f9a,Silver,82.47
45.23,30.23,Not Rated,31.75,26.19,National Audit of Care at the End of Life - organisational level audit,22.22,ALLIANCE > HQIP,1.1.7,a290592c-a6f5-4874-b283-1d33e923c487,535fbfd4-34f0-436d-8de2-e708fd0fa103,Not Rated,47.98
77.78,27.91,Bronze,26.98,73.81,Ventilatory strategies and outcomes for patients with COVID: a dataset in OMOP,82.54,HUB > PIONEER,1.1.7,cacba424-6c2c-4b57-8f5b-64e92a78370a,53b7c446-667b-409e-920e-67cb516de3ae,Silver,72.95
73.81,32.56,Bronze,33.33,71.43,COVID19 Vaccination Status,80.95,ALLIANCE > NHS DIGITAL,1.1.7,98372a87-f3e6-475d-be12-46c0f9587413,53daaea6-46e8-4665-b50d-5c86396b3bbf,Bronze,69.44
73.02,32.56,Bronze,36.51,76.19,Business Impact of COVID-19 Survey (BICS),82.54,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,8e739a01-bcfa-4b75-b7f8-e694ee185f8d,542baa13-5d19-424e-b747-b2e57922df01,Bronze,71.81
69.84,20.93,Bronze,20.63,69.05,Epilepsy Society Brain and Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,f13258c3-f85a-4772-b42e-da8a84c5064a,54a7dd45-d6c7-4b4d-801d-2becd2b694f1,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry - Lower Limb Angioplasty clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,c8b6c319-239b-4792-9898-644a63d07ab5,5536b00a-fb31-4e91-9bd8-e7f774974846,Not Rated,47.98
88.09,23.26,Silver,23.81,95.24,National Community Child Health Database (NCCHD),100.0,ALLIANCE > SAIL,1.1.7,20fe153c-a5e5-4991-900e-8fa9988e771a,553a0fcb-6bed-493c-a185-fa97dc5f370d,Gold,85.99
67.46,16.28,Bronze,19.05,61.9,Care-seeking practices for childhood pneumonia in non/tribal areas of Pune India,53.97,HUB > BREATHE,1.1.7,4346676d-6108-47de-b579-6cef74c6acef,561b8a79-6bac-4ffc-91f4-0bbec4e90968,Bronze,72.81
69.84,20.93,Bronze,20.63,69.05,LBIH Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,c0318a31-a32c-4d3a-9591-dfe9352bf2b9,567b23fe-abf2-4e2e-88f7-505dfeaa3cde,Bronze,74.06
77.78,25.58,Bronze,25.4,73.81,"Diabetic Eye Screening: the Birmingham, Solihull and Black Country Data Set",80.95,HUB > INSIGHT,1.1.7,36886b21-12ff-45e7-82bc-fb5308c12450,56c3aabb-cb99-4da9-a6ed-3212c02e6f20,Silver,74.12
69.05,23.26,Bronze,22.22,69.05,TNT: Triple Negative breast cancer Trial,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,5f4c825d-d6c3-453e-9667-8cdf2329b6e1,56f3e791-a204-4f67-a4d0-52803148d71a,Bronze,72.89
40.48,37.21,Not Rated,36.51,21.43,Tayside & Fife Diabetes – Summary and a range of diabetes related datasets.,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,49e63323-e564-48ac-9f11-cf77bf0fe20b,5852d8bc-d721-4daf-a63b-21aebcc6f5a9,Not Rated,42.11
65.87,18.6,Bronze,19.05,57.14,Labour Force Survey (Longitudinal),50.79,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,4ac15572-fe9a-46d3-860d-a46b616181f7,598989e4-17b7-4730-87af-b7e6b1519301,Not Rated,69.27
44.45,32.56,Not Rated,33.33,26.19,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (therapist survey),22.22,ALLIANCE > HQIP,1.1.7,bf2d780d-936b-4f4c-88f9-a280b849b652,59bc96f9-69b7-4763-81a8-ec4695b6b55e,Not Rated,46.81
73.02,32.56,Bronze,31.75,69.05,Enhanced Prescribing Database,77.78,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,1.1.7,2843087f-23a4-4cfe-8e72-53f2b9562cc3,5ae869f8-b6af-41c0-bca0-1fffef112375,Bronze,68.25
66.66,30.23,Not Rated,34.92,59.52,MATCH,68.25,ALLIANCE > HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,5429fc2a-3d72-414d-9393-4079c4c6c0fa,5b99795a-3db4-4020-a8f9-aa64bcc2c5f0,Bronze,64.64
81.75,27.91,Silver,33.33,92.86,North West London Accident and Emergency Data (NWL A&E),96.83,HUB > DISCOVER NOW,1.1.7,721db252-8069-433d-bb6d-4b44b243d364,5b9b7964-615b-438a-b151-d2f884a24aee,Silver,82.47
69.84,20.93,Bronze,20.63,69.05,VinCaP,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,e57dd7a2-3c5c-4285-8001-8e2589c395e9,5bb40472-fc5d-4b16-a0a6-d1d42fd1d3e8,Bronze,74.06
54.77,32.56,Not Rated,33.33,52.38,International Severe Asthma Registry,42.86,HUB > BREATHE,1.1.7,9711e6cc-426c-4cef-afb3-64382f8d7ed4,5c7ae78d-53e6-427d-a3a9-52538f8342dc,Not Rated,59.91
79.37,9.3,Silver,11.11,78.57,SpiroMeta Consortium Dataset,69.84,HUB > BREATHE,1.1.7,fb6d98c5-e41d-4804-bb28-839556e0f657,5d2758c6-b315-421f-9971-9df8ba83a2d4,Silver,84.63
76.19,32.56,Bronze,33.33,78.57,Diagnostic Imaging Dataset,85.71,ALLIANCE > NHS DIGITAL,1.1.7,86f46be3-bc29-4820-8363-de6530a94c6f,5d76d094-446d-4dcc-baa1-076095f30c23,Silver,73.0
37.3,39.53,Not Rated,39.68,16.67,ARIA Radonc,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,59d72237-6969-4f59-9e87-48138978abe8,5e022f8f-4d07-44bb-a87c-43e31200fe1e,Not Rated,38.57
83.34,23.26,Silver,30.16,92.86,North West London Mental Health Data (NWL MH),96.83,HUB > DISCOVER NOW,1.1.7,2d3ec99a-a087-4355-8539-5a22cef58910,5e19a471-64e3-4aa4-ac56-6901d5e39e28,Silver,84.8
87.3,20.93,Gold,25.4,95.24,Emergency Department Dataset Daily,100.0,ALLIANCE > SAIL,1.1.7,fa257aa8-51fc-4eb7-a448-e473fa54686d,5e2a7277-dc64-499a-b16d-51850d9ad00b,Gold,87.16
42.86,34.88,Not Rated,36.51,26.19,National Paediatric Diabetes Audit - core clinical dataset (care processes and outcomes),22.22,ALLIANCE > HQIP,1.1.7,e355c9b9-44f0-4ba3-a872-645aa88f4f2b,5ea9c568-b850-4589-bcbb-6ee0cfd322cd,Not Rated,45.66
45.23,30.23,Not Rated,31.75,26.19,National Maternity and Perinatal Audit Organisational Survey 2019,22.22,ALLIANCE > HQIP,1.1.7,01ad25ed-8cde-43d7-bc77-d8cc3d165df4,600be397-211b-4f65-9f82-e85f4393fb8a,Not Rated,47.98
84.92,25.58,Silver,30.16,95.24,North West London population data (NWL POP),100.0,HUB > DISCOVER NOW,1.1.7,1032850f-7631-4d9e-a760-b0532bffd21a,601f1504-2706-405b-94cb-8cd14231f434,Silver,84.83
69.84,20.93,Bronze,20.63,69.05,STAMPEDE,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,71eb0192-1124-4b27-86e4-1139e0047a02,60b148f7-b48c-49c4-9286-b83691cfc7b2,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Clinical Audit of Anxiety and Depression - Core audit of practice,22.22,ALLIANCE > HQIP,1.1.7,4a96b9bf-beb0-41b1-9211-e6ce39a21c1a,61cf3b8d-5a1b-4241-aaac-89599bf17ab6,Not Rated,47.98
75.4,32.56,Bronze,33.33,76.19,Census 2011 E&W - Household structure for COVID-19 models,84.13,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,2f66bcf9-e626-4e8d-bc6e-2d3958e709d8,62087504-c04e-4382-9c71-e1c9b83d2d5e,Bronze,71.81
73.02,34.88,Bronze,34.92,73.81,Emergency Care Data Set (ECDS),80.95,ALLIANCE > NHS DIGITAL,1.1.7,7749d90e-dd7a-4697-8a9c-666491c64a0c,621008c7-67ac-4e3d-9c54-af87cc2f9579,Bronze,69.47
81.75,20.93,Silver,23.81,80.95,Scottish Birth Record (SBR),87.3,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,81c53293-ef64-4507-8fcf-2a254dc19936,621576c2-a995-424b-a506-2276f9b03f37,Silver,80.01
71.43,13.95,Silver,17.46,71.43,ICT-based intervention for adult asthma with limited health literacy,60.32,HUBS > BREATHE,1.1.7,1d6b02f1-47b8-42ad-919d-f738b545cff7,62824365-480a-4d20-9ab2-7e7739e7e2ec,Bronze,78.74
84.92,27.91,Silver,30.16,95.24,GENOMICS ENGLAND 100K PHE LINKED DATA,100.0,GENOMICS ENGLAND,1.1.7,ea748742-568a-46e2-b603-2fada49024e1,62c01293-83a5-4d4d-9d36-9d7aa2bf120f,Silver,83.66
91.27,16.28,Gold,17.46,95.24,COVID-19 Symptom Tracker Dataset,100.0,ALLIANCE > SAIL,1.1.7,594cfe55-96e3-45ff-874c-2c0006eeb881,6325125b-6157-4c20-8bc0-54e2c45cf19b,Gold,89.48
73.02,30.23,Bronze,36.51,73.81,SICSAG Daily (Scottish Intensive Care Audit Group),82.54,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,811a54fb-8b79-442f-8e28-a725a0561a15,63f9444f-d23b-425c-9ee5-aa09968afa08,Bronze,71.79
45.23,30.23,Not Rated,31.75,26.19,National Audit of Dementia Round 4 - organisational checklist,22.22,ALLIANCE > HQIP,1.1.7,0a305b29-cf23-4261-9299-5251e41ee9f0,64a0ba4d-776c-4979-a4b0-1f1fb6b61c85,Not Rated,47.98
84.92,23.26,Silver,26.98,90.48,Higher Education Statistics Agency (HESA) Student Data,96.83,ALLIANCE > SAIL,1.1.7,68b04d3b-17b4-4a04-a8a3-e2a93ed231df,64c6a583-f71b-478e-a26b-5e581226ec6d,Silver,83.61
86.5,20.93,Silver,25.4,92.86,Diagnostic and Therapy Services Waiting Times,98.41,ALLIANCE > SAIL,1.1.7,97896866-ab5e-408a-ac5a-072802db9faf,65c8a30c-de2c-47bf-87e4-18c86e75e54a,Gold,85.97
69.84,20.93,Bronze,20.63,69.05,interNational Anaplastic Thyroid Cancer Tissue Bank (iNATT),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,5ef75d71-73ce-4451-9d7a-a39dd82b712f,6620b221-6909-4106-a49e-f1b5820be2f3,Bronze,74.06
78.58,34.88,Silver,39.68,92.86,The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) primary care sentinel network and database,96.83,ALLIANCE > ROYAL COLLEGE OF GENERAL PRACTITIONERS,1.1.7,d5049af5-e351-4b22-8f75-6f3dfc96419b,664513d6-d766-461d-a69e-206a928cd14f,Silver,78.99
87.3,20.93,Gold,25.4,95.24,Critical Care Dataset,100.0,ALLIANCE > SAIL,1.1.7,1789286a-deaf-49df-88cd-660e92934af6,67ae329c-f51e-4a28-9a1c-e35d2819a6c3,Gold,87.16
77.78,16.28,Silver,15.87,80.95,Genetics of Asthma Severity & Phenotypes,71.43,HUB > BREATHE,1.1.7,6277abc6-c039-4886-8489-d4a2cdb8190c,67cd0c2b-3944-4bc4-a03a-4081ee67847f,Silver,82.34
87.3,20.93,Gold,25.4,95.24,COVID-19 Shielded People list,100.0,ALLIANCE > SAIL,1.1.7,dc22db56-8791-4e96-9ce6-6b6a58b1241f,67ef8ade-51e6-4737-acee-be871751a698,Gold,87.16
61.91,20.93,Not Rated,22.22,52.38,Exploring the provision of supportive care for patients with COPD in Malaysia,46.03,HUB > BREATHE,1.1.7,af8cdc87-789e-4bea-9d8b-927aa689d211,68eca6a2-7c32-4bea-bcd1-c07dc50ee018,Not Rated,65.72
84.92,23.26,Silver,26.98,92.86,North West London Patient Index (NWL PI),96.83,HUB > DISCOVER NOW,1.1.7,1fe1e7bb-ef6e-4d89-9824-bb560afc81f0,6a390359-1e26-470f-a4e5-bfb31a5ed643,Silver,84.8
56.35,48.84,Not Rated,47.62,47.62,Systemic Anti-Cancer Treatment (SACT) data for CPRD GOLD,60.32,ALLIANCE > CPRD,1.1.7,014e7973-b43e-4a4a-91b4-de3f353b71b9,6a8066c7-a8f4-44a6-9efd-871b19a3689f,Not Rated,49.39
71.43,20.93,Bronze,20.63,71.43,York Tissue Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,71e898d1-db8c-4887-a605-dd6336b92a34,6aebcd6d-10c6-44cd-80d6-b5a90791db4f,Bronze,75.25
45.23,30.23,Not Rated,31.75,26.19,National Diabetes Audit - National Diabetes Foot Care Audit clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,dabf34b3-7368-4097-94c5-5b4f4be68fc6,6b53f274-c927-4b8f-bcc3-1d85fabf16ee,Not Rated,47.98
88.09,20.93,Silver,22.22,92.86,Welsh Dispensing Dataset,98.41,ALLIANCE > SAIL,1.1.7,50ef6443-ed4b-40f9-97fb-1cfd53be6579,6b7893b5-74bc-49e2-ab4d-50e7695f54a5,Gold,85.97
71.43,25.58,Bronze,23.81,76.19,Sheffield Brain Tissue Bank (SBTB),66.67,ALLIANCE > TISSUE DIRECTORY,1.1.7,bdda7221-7c02-4ced-b7a8-3806a073d981,6bc36f07-d55a-4a97-afab-29d93dc65bde,Bronze,75.31
72.22,18.6,Bronze,17.46,69.05,Leicester Respiratory Research Database,61.9,HUB > BREATHE,1.1.7,01c3d08c-6948-4059-a027-3437e4f5d53b,6bca5d27-5b98-45e7-b834-6980ba5db5c9,Bronze,75.22
69.84,20.93,Bronze,20.63,69.05,Leeds Breast Research Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,2dc1218d-df5f-4025-826c-cf5ca7d67882,6bde3902-5d69-4c24-9d10-f84a63efdb22,Bronze,74.06
76.19,30.23,Bronze,31.75,76.19,Covid-19 Second Generation Surveillance System,84.13,ALLIANCE > NHS DIGITAL,1.1.7,fede31c6-a9c5-4cfb-9866-9b58b2199cff,6c878d69-2662-42db-85da-15e087606442,Silver,72.98
69.05,25.58,Bronze,25.4,71.43,DARWIN1 Trial,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,7f9672fa-dad5-479d-a929-52719e8cc2fa,6ceec25d-2c8e-4dd7-8f99-2e56ec63c298,Bronze,72.93
44.45,32.56,Not Rated,33.33,26.19,National Joint Registry - Revision Elbow Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,12babf2b-42e8-4b1e-9143-3475a07bb343,6d1b9b23-1197-4857-9b17-9e26cb0633e8,Not Rated,46.81
47.62,37.21,Not Rated,36.51,35.71,Emergency Care Dataset (ECDS),31.75,ALLIANCE > BARTS HEALTH,1.1.7,57fa56f2-78d1-49af-ab8d-e8146d711868,6d41700e-6dac-47c1-ba31-eb2f23539efe,Not Rated,49.25
40.48,37.21,Not Rated,36.51,21.43,NHS Tayside and Fife Virology,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,855a84b2-9d58-4b2b-a450-b6c6d534e403,6dd0f10d-82fa-438f-ba74-9c880f60bf4c,Not Rated,42.11
69.84,20.93,Bronze,20.63,69.05,Wales Cancer Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,37886fb5-d0ae-400f-89eb-78664897bcf2,6dd6c679-7c5f-4d8e-b1e4-8f1447425e96,Bronze,74.06
69.84,39.53,Not Rated,39.68,71.43,HES Outpatient data for CPRD Aurum,79.37,ALLIANCE > CPRD,1.1.7,8d3f3e58-be79-4450-b2e3-f5ab8a25fb0e,6e1d8f50-f718-4964-9c88-2c80cbaa92b5,Bronze,65.95
73.81,32.56,Bronze,33.33,71.43,COVID19 Vaccination Adverse Reaction,80.95,ALLIANCE > NHS DIGITAL,1.1.7,080a90e4-4bc6-4153-a4c6-c120eef5ba94,6e20e516-97d4-4cdc-b41b-107ed3fc02f5,Bronze,69.44
55.55,27.91,Not Rated,25.4,40.48,Biological samples,36.51,UK Biobank,1.1.7,41ac38b0-31cd-4865-a357-80ce557b2312,6e5916d4-017c-4542-bc71-edf6d4c5a055,Not Rated,56.28
50.8,34.88,Not Rated,34.92,42.86,"Trusted Research Environments for CVD-COVID-UK in England, Scotland and Wales",36.51,OTHER > BHF Data Science Centre,1.1.7,7e5f0247-f033-4f98-aed3-3d7422b9dc6d,6ec3a47b-447a-4b22-9b7a-43acae5d408f,Not Rated,53.99
45.23,30.23,Not Rated,31.75,26.19,Epilepsy 12 - Patient Reported Experience Measure,22.22,ALLIANCE > HQIP,1.1.7,cefa4d82-5a22-4c19-82ab-4663a364e49e,6efbc62f-6ebb-4f18-959b-1ec6fd0cc6fb,Not Rated,47.98
88.89,20.93,Gold,22.22,95.24,COVID-19 Test results,100.0,ALLIANCE > SAIL,1.1.7,f5f6d882-163d-4ef1-a53e-000fba409480,6f24a4b8-66ab-4ea7-aa8c-3be3d0b4abf1,Gold,87.16
79.37,27.91,Silver,31.75,83.33,Intensive Care National Audit and Research Centre,90.48,ALLIANCE > SAIL,1.1.7,fa8bf269-4769-491b-b398-fa63137d14ab,6f348bdc-21e4-459b-b658-dc839a1e2133,Silver,77.71
69.05,25.58,Bronze,25.4,71.43,National Joint Registry - Primary Hip Replacement dataset,63.49,ALLIANCE > HQIP,1.1.7,03280e87-6975-4a2a-967d-b332cb788e44,7038a67d-34ca-4754-a50f-41aa2849db69,Bronze,72.93
69.05,23.26,Bronze,22.22,69.05,CASPS: A Phase II trial of Cediranib in ASPS patients,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,7dcd5c0a-1922-4fe2-9b7e-090e4c39861b,70b4d407-288a-4945-a4d5-506d60715110,Bronze,72.89
69.84,25.58,Bronze,25.4,73.81,Avon Longitudinal Study of Parents and Children,65.08,ALLIANCE > AVON LONGITUDINAL STUDY OF PARENTS AND CHILDREN,1.1.7,255d70c6-9a50-4b62-adc0-44216606a216,71b8569c-b582-499c-85aa-909b825f6ea6,Bronze,74.12
37.3,39.53,Not Rated,39.68,16.67,Infoflex Cancer Registry,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,5505e91d-9e0a-4969-87d5-00f256d91306,72fe91de-b0c0-423a-ad68-bd7067b20ad8,Not Rated,38.57
80.16,25.58,Silver,25.4,78.57,"Deeply-phenotyped hospital COVID patients: severity, acuity, therapies, outcomes",85.71,HUB > PIONEER,1.1.7,16a09f1b-3654-4ec3-9913-fb70cb1e2364,730b3e54-1f59-4c07-b5d6-e6b63e4dda35,Silver,76.5
76.19,16.28,Silver,17.46,78.57,UK BiLEVE Consortium Dataset,69.84,HUB > BREATHE,1.1.7,b8bcda0b-3c90-4382-aeb7-b01fc27e58fa,73462506-32c5-43a0-963e-06d67e967b97,Silver,81.14
66.67,18.6,Bronze,20.63,61.9,"Prevention, detection, treatment: adult lung disease/cancer in rural Tamil Nadu",53.97,HUB > BREATHE,1.1.7,2581994d-5be2-4465-bb62-60c4c97e8e2b,736a9d09-83c7-4cfa-ae82-a10b2a69efc8,Bronze,71.65
85.72,23.26,Silver,28.57,95.24,Annual District Death Daily,100.0,ALLIANCE > SAIL,1.1.7,584bf8c8-d58f-44c6-9b65-e1611144fd54,73867034-fe12-4d23-8d11-66da716dcb3d,Silver,85.99
73.02,32.56,Bronze,31.75,69.05,COVID antigen testing - Pillar 1,77.78,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,1.1.7,3abc20ce-3dc6-4715-9de0-56aa97a6f5ec,7389dc03-1fc7-4af7-b12c-bbab448290f9,Bronze,68.25
45.24,32.56,Not Rated,34.92,30.95,Labour Force Survey (Person),25.4,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,8c60a308-1e47-4a0c-8b69-9259f05338cb,73ba9de7-67fe-4728-b397-bc5fb1d67df1,Not Rated,49.2
73.81,46.51,Bronze,52.38,95.24,HIC Hepatitis v2,100.0,NIHR Health Informatics Collaborative Viral Hepatitis Theme,1.1.7,66be725a-b950-4bf8-9a35-7e33ce765a25,73f54071-62bf-48f5-8be1-569208b18ab8,Bronze,74.36
69.84,20.93,Bronze,20.63,69.05,Myeloma XII clinical trial samples,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,576fbcf8-ff25-4230-ae69-e72ca02b95f1,74241b17-23b7-4233-b7b9-1a484aa053b0,Bronze,74.06
68.25,18.6,Bronze,20.63,66.67,Effects of second-hand smoke on pregnant women: a phenomenological study,57.14,HUB > BREATHE,1.1.7,4a5c610f-019d-450a-90c5-0fe315027f56,7480abe4-e073-40ef-882d-217542b5e08e,Bronze,74.03
55.56,30.23,Not Rated,26.98,42.86,Cancer register,38.1,UK Biobank,1.1.7,a4751434-54ea-4d22-a66a-a5d32bd80c40,75614b69-bc18-416b-9d27-fd8ca9fc4521,Not Rated,56.31
75.4,39.53,Bronze,39.68,83.33,CPRD GOLD,90.48,ALLIANCE > CPRD,1.1.7,a29feafa-7bdd-44e9-b977-c9d26425e67f,756daeaa-6e47-4269-9df5-477c01cdd271,Bronze,71.9
79.37,27.91,Silver,31.75,83.33,Intensive Care National Audit and Research Centre - Covid19,90.48,ALLIANCE > SAIL,1.1.7,add6226b-0f21-439a-84a6-51dc26cdc425,7639cdc3-f368-4a43-80bd-58a67e70d407,Silver,77.71
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): secondary care workstream – children and young people asthma (organisational),22.22,ALLIANCE > HQIP,1.1.7,3efd9b30-1f84-48c0-a3e0-402ecb5c7724,76ec0282-02e0-4fff-b016-76bc6ffcb784,Not Rated,45.66
88.89,20.93,Gold,22.22,95.24,The National COVID-19 Chest Imaging Database,100.0,NHSX,1.1.7,31f0148b-f965-4136-ab39-6c5bbbf8c2d9,77824298-ef3b-40f7-a0a4-b6dedb2e7a02,Gold,87.16
71.43,20.93,Bronze,20.63,71.43,Leeds Multidisciplinary Research Tissue Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,7e60a651-b3d6-40ef-93dc-1f87dabee7be,7793f54e-73be-4c97-a941-ba105b1b0480,Bronze,75.25
69.84,37.21,Not Rated,38.1,69.05,HES Admitted Patient Care data for CPRD GOLD,77.78,ALLIANCE > CPRD,1.1.7,4bcf64a6-f404-4ef4-ae6e-172512ab5f43,77b5cf84-d4f2-4418-bafa-73306cf2d2b2,Bronze,65.92
47.62,46.51,Not Rated,50.79,35.71,NHS Tayside and Fife Haematology Biochemistry (Lab Data Restructured),46.03,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,10ffac16-d0c2-4d53-ab6a-69a38e283223,7858978f-30e8-42e7-abe4-d9af5447c278,Not Rated,44.6
71.43,20.93,Bronze,20.63,71.43,UCL / UCLH Biobank for Studying Health and Disease,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,ce533c67-5565-4010-bedf-dca3863a9084,7862c1c2-d4d6-4b3c-aea1-1f15a5b3b5ea,Bronze,75.25
44.45,32.56,Not Rated,33.33,26.19,National Audit of Psychosis - Early Intervention Psychosis Audit patient experience survey,22.22,ALLIANCE > HQIP,1.1.7,a464c126-8591-4af6-a10f-99c020f59527,78d25670-9d20-4eb7-a79a-f29e53cc981f,Not Rated,46.81
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4.1 (Sensitive) Episodes,77.78,ALLIANCE > NHS DIGITAL,1.1.7,efecbe58-4822-4f17-bf5c-92113d143db9,78fe2e13-7f40-406f-a584-04909d0ce060,Not Rated,56.57
53.18,25.58,Not Rated,28.57,40.48,EMEP4UK Pollution,34.92,HUB > BREATHE,1.1.7,eb76598f-e228-413c-82f3-231809062611,79116473-bda2-413c-82ad-ba2b86e5076f,Not Rated,57.45
78.57,32.56,Silver,34.92,88.1,National Cancer Registration and Analysis Service,92.06,PUBLIC HEALTH ENGLAND,1.1.7,0a852454-ee67-443b-a091-d13499a71b41,79a7ad18-6941-4543-924a-787f2381f5e0,Silver,77.77
70.64,23.26,Bronze,22.22,71.43,Central England Haemato-oncology and oncology Research Biobank (CEHRB),63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,314953f6-58e7-49c0-adfd-c60e623eba74,79b02690-798b-462d-9ced-f53c9e39d624,Bronze,74.09
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,1a8fc23c-b67b-4171-b5e1-1b650fce1ef4,7aa02796-787a-42c2-b97e-d008fa77e4b8,Not Rated,56.57
72.22,34.88,Bronze,34.92,73.81,Moorfields AMD Dataset Release 002,79.37,HUB > INSIGHT,1.1.7,bf392537-82b4-4d71-ace0-e7bea3b167fb,7aab11a7-6fff-4e4a-a480-b48ccc6bad87,Bronze,69.47
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): Adult Asthma secondary care clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,becd2624-9a01-4f01-bcf8-56e94545a49a,7dc319da-a16f-4e63-a115-0cba3905a322,Not Rated,45.66
44.45,32.56,Not Rated,33.33,26.19,Epilepsy 12 - National organisational audit (service descriptor questionnaire) and Trust profile,22.22,ALLIANCE > HQIP,1.1.7,2c737d63-69f4-4a02-8df9-54c1e65e845f,7f125091-12ba-464d-af7d-9a88179b0b95,Not Rated,46.81
82.54,27.91,Silver,30.16,88.1,UHB Eye Image Dataset Release 001,95.24,HUB > INSIGHT,1.1.7,21fb56d1-726f-40e3-a998-e4b34ba3e46f,7f4fb30c-2a09-4d75-bed2-114751e06723,Silver,80.09
44.45,32.56,Not Rated,33.33,26.19,"National Audit of Dementia - spotlight audit on the prescription of psychotropic medication, 2019",22.22,ALLIANCE > HQIP,1.1.7,949d9d7a-a3f1-480a-8563-3fb024300561,7fab080b-6e2a-4c82-a5e5-daf99c70662a,Not Rated,46.81
84.12,30.23,Silver,31.75,95.24,GENOMICS ENGLAND 100K CANCER & COMMON,100.0,GENOMICS ENGLAND,1.1.7,702f0198-bdfe-401e-97f2-35f5d26357ad,7fdb684d-bb7a-4d0b-8666-9f10510f071f,Silver,82.5
63.5,18.6,Bronze,20.63,54.76,Developing Patient and Public Involvement in Research in Malaysia,47.62,HUB > BREATHE,1.1.7,153c0ba6-f2ec-4fb4-b5a7-33e11cbdf7fc,7fe20f78-758d-4449-beb4-ccf98e2d8247,Not Rated,68.08
69.84,32.56,Bronze,41.27,71.43,NHS Scotland General Practice (GP) Contact Data - Subset,80.95,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,8f486c3d-9504-4a0e-8e24-ab96f057fc9e,80b54fc9-8dc0-4134-880d-ffa8d4473204,Bronze,69.44
89.69,18.6,Gold,20.63,95.24,Cervical Screening Wales,100.0,ALLIANCE > SAIL,1.1.7,b32325d7-7f00-4d20-9935-dd02e1bc6932,80e9c439-4909-4534-8bfe-6f01fdec7de7,Gold,88.32
78.57,27.91,Bronze,26.98,76.19,Risk and outcomes of coagulopathies in acutely unwell adults,84.13,HUB > PIONEER,1.1.7,bf3fe16c-5377-4571-b5a5-7aa7e796594c,81c54c5a-ceb1-487c-820a-437b4dd002ca,Silver,74.14
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Episodes,77.78,ALLIANCE > NHS DIGITAL,1.1.7,a27400b0-0efb-4af8-a7bc-e2c7e59796e3,8226b6fa-d815-4f15-9064-b56beb0fddb1,Not Rated,56.57
82.54,25.58,Silver,25.4,83.33,Maternity Inpatient and Day Case - Scottish Morbidity Record (SMR02),90.48,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,d47c809f-3da8-4f8a-b1ee-258d21aad530,824e20d9-217a-4028-bb49-91164edcca00,Silver,78.88
71.43,25.58,Bronze,23.81,76.19,Research Donors Ltd,66.67,ALLIANCE > TISSUE DIRECTORY,1.1.7,fcb62cb3-c876-47a3-961e-fb27c6f718fa,826114ca-2563-4c0c-b023-3417ead32956,Bronze,75.31
45.23,30.23,Not Rated,31.75,26.19,National Audit of Dementia Round 4 - staff questionnaire,22.22,ALLIANCE > HQIP,1.1.7,ef6e68d6-dcba-410c-943c-26ca21376a3a,82665c1e-df7f-4136-a05f-0826533149e5,Not Rated,47.98
89.69,18.6,Gold,20.63,95.24,National Exercise Referral Scheme,100.0,ALLIANCE > SAIL,1.1.7,131784c0-769d-4f7b-b7d0-b5f4b89886d4,8270e26b-65ea-479c-8462-f5315b2657eb,Gold,88.32
71.43,20.93,Bronze,20.63,71.43,Northern Ireland Biobank (NIB),63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,c6e1ea88-f5bf-4a57-953f-688f313fcb04,82f4cf19-9e6a-4c31-8cc3-085f3d44ba44,Bronze,75.25
76.19,44.19,Bronze,47.62,95.24,HIC Acute Coronary Syndromes,100.0,NIHR Health Informatics Collaborative Cardiovascular Theme,1.1.7,869a9b4e-3537-449f-9a59-a0eac523c4e4,844f3be0-f50d-4a88-9783-0928ad1c2aad,Silver,75.53
69.84,20.93,Bronze,20.63,69.05,"Oncology Clinical Trials Office, University of Oxford",60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,4a65f6d6-f2e4-4d98-a3a4-94a32206836d,8466ec6f-8a4c-4286-8138-04c35e12b1f8,Bronze,74.06
57.94,25.58,Not Rated,23.81,45.24,COMPARE,39.68,OTHER > The University of Cambridge,1.1.7,8cbb73e2-a2c4-4caf-8dcd-6ac3795bb996,84b6d047-2a05-4fc0-8537-809dbb3d18ed,Not Rated,59.83
37.3,39.53,Not Rated,39.68,16.67,CRIS,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,67cea834-33f5-4ed7-9dc2-072ad077de07,84de0d13-f5bd-4c22-83d3-e1adb00d5a72,Not Rated,38.57
84.13,25.58,Silver,28.57,92.86,North West London Coordinate My Care (NWL CMC),96.83,HUB > DISCOVER NOW,1.1.7,c853b41b-fbd1-4896-b0fb-85303109fec4,850f99cb-f091-4f10-86ee-06a3eaa7df53,Silver,83.64
56.35,48.84,Not Rated,47.62,47.62,Cancer registration data for CPRD Aurum,60.32,ALLIANCE > CPRD,1.1.7,3f3df3be-05a8-42b2-89d9-f731deb7ea66,851bb11b-fa75-44ee-afe9-948dc7652555,Not Rated,49.39
45.23,30.23,Not Rated,31.75,26.19,National Diabetes Audit - National Diabetes in Pregnancy clinical Audit dataset,22.22,ALLIANCE > HQIP,1.1.7,7c789df2-46f0-4e0e-b6ff-b04dce801445,858c517e-8ce3-4059-9326-d158489e48d1,Not Rated,47.98
69.84,39.53,Not Rated,39.68,71.43,HES Outpatient data for CPRD GOLD,79.37,ALLIANCE > CPRD,1.1.7,21dc2345-3983-4a46-960c-f17974bc7b71,8625eb42-93df-4d33-875b-e6a93413d7ba,Bronze,65.95
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Tendon Rupture,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,4fcc8b11-2b9b-4f68-b51a-978749d89acc,8638e095-a609-463f-b36e-c4cac4519660,Silver,83.66
69.05,23.26,Bronze,22.22,69.05,Oxford Musculoskeletal Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,ccd6e59d-3582-4f47-a4cd-f5845192d75c,865f0e79-f862-493b-b863-b39b777d60ca,Bronze,72.89
76.98,13.95,Silver,14.29,78.57,Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS),68.25,HUB > BREATHE,1.1.7,cc6f926a-90cf-4083-84e7-131d1e63813b,8665b36e-f9a5-4062-ba56-d33fecfe3376,Silver,82.31
64.28,44.19,Not Rated,47.62,64.29,HES:Civil Registration (Deaths) bridge,76.19,ALLIANCE > NHS DIGITAL,1.1.7,21aec912-444f-447d-b3c4-6791a6c82667,86d7088b-7a15-4e9a-b2b0-857a67e04650,Not Rated,60.05
67.46,41.86,Not Rated,42.86,69.05,Death Registration data for CPRD GOLD,77.78,ALLIANCE > CPRD,1.1.7,1d35e229-13eb-4be1-9dae-4752b6c27c4a,87244819-4596-4e5d-baaa-f3fe4eb74b4b,Bronze,63.59
43.65,32.56,Not Rated,34.92,26.19,National Early Inflammatory Arthritis Audit - clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,b0797c05-352f-455f-8d27-150b6f6354cc,875999d5-f5ed-4136-ac20-b20f1abe27dd,Not Rated,46.81
69.84,20.93,Bronze,20.63,69.05,University of Southampton Faculty of Medicine Tissue Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,786563e9-5377-4d18-8d32-65ff14d53987,88576066-fb5f-43e2-8af4-0904630b2f1b,Bronze,74.06
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v2.6 (Non-Sensitive),77.78,ALLIANCE > NHS DIGITAL,1.1.7,702201ff-e729-4e29-a428-32953c9a0332,895e5c2f-e484-4d08-91c6-35ac2f85c231,Not Rated,56.57
69.84,20.93,Bronze,20.63,69.05,Human Biomaterials Resource Centre,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,2f085ac6-d33d-4b9b-8a99-624cc51c3f17,89aac17d-f8a1-4ddc-9495-4adc278234a9,Bronze,74.06
75.39,34.88,Bronze,34.92,78.57,Hospital Episode Statistics Outpatients,85.71,ALLIANCE > NHS DIGITAL,1.1.7,d4362d41-0838-4f41-bba3-c3268312c444,8a05b76d-b0ec-4c28-96b5-11601e26933a,Bronze,71.84
40.48,37.21,Not Rated,36.51,21.43,Fife Radiology,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,d020302b-a691-49fb-9d10-1274af2f3110,8a128e75-0188-40a3-94d4-5f1967fcffb2,Not Rated,42.11
60.31,46.51,Not Rated,42.86,50.0,Patient postcode linked deprivation measures for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,bd85a09c-fe4a-41b8-81d2-77feadcd1a0a,8ab1dc13-634e-46ae-9ba0-e094d446bd74,Not Rated,51.75
75.39,32.56,Bronze,34.92,78.57,NIHR BioResource: Demographic,85.71,ALLIANCE > NIHR BIORESOURCE,1.1.7,d2c486bb-b95b-4093-bb58-b196cfc08c7b,8c573599-30cf-4708-bcbd-e2e37c795664,Bronze,73.0
37.3,41.86,Not Rated,41.27,19.05,Sectra PACS,15.87,ALLIANCE > BARTS HEALTH,1.1.7,10bf4c08-6702-44fe-8faa-1280dea6b0c9,8c7abca7-4292-4d1f-b311-c132a7adf109,Not Rated,38.59
82.54,16.28,Silver,17.46,76.19,Child Health Systems Programme - 6-8week review,82.54,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,f9cf4be7-fbc9-4601-8beb-5d3c3596bf04,8cfbaeec-98ce-4e09-b49c-d7c5968f1e85,Silver,79.95
64.28,46.51,Not Rated,49.21,64.29,Bridge file: Hospital Episode Statistics to Mental Health Minimum Data Set,77.78,ALLIANCE > NHS DIGITAL,1.1.7,31bb8022-f8b1-405a-a22f-140f7c4b4fa6,8d3f80d4-aeae-46f0-809b-cd6c51e24f75,Not Rated,58.89
65.08,34.88,Not Rated,39.68,61.9,REal-time Assessment of Community Transmission (REACT-2),69.84,ALLIANCE > IMPERIAL COLLEGE LONDON,1.1.7,25003f25-384c-4264-9c8f-dd8734ee5595,8e5e3ebe-c0ae-458f-bc75-a5a3368d4c2d,Not Rated,63.51
65.87,32.56,Not Rated,31.75,52.38,Community Services Data Set,63.49,ALLIANCE > NHS DIGITAL,1.1.7,5616e0a6-22f1-43a5-a2bd-dcecfa2f3b70,8e66e623-2859-4a65-93d7-abd41e139976,Not Rated,59.91
88.89,20.93,Gold,22.22,95.24,Outpatient Dataset,100.0,ALLIANCE > SAIL,1.1.7,d331159b-b286-4ab9-8b36-db39123ec229,8e6d7fcc-a4ad-4a32-bbc2-fe8631a38b43,Gold,87.16
54.76,39.53,Not Rated,36.51,47.62,Mental Health Services Data Set - Inpatients,46.03,ALLIANCE > NHS DIGITAL,1.1.7,275ac6a4-798b-4f49-a25e-008245050bbc,8eace3c2-1dc8-4708-9350-ad129b7d2bc9,Not Rated,54.05
78.57,27.91,Bronze,26.98,76.19,The impact of hospitalised patients with COPD: from admission to outcome,84.13,HUB > PIONEER,1.1.7,780bf7d0-9ee1-4641-a74f-dc148e361970,8fac682b-96be-4e21-a2a9-5fe66c3b35ff,Silver,74.14
70.63,13.95,Silver,17.46,69.05,Pneumonia case management practices in selected communities in Pakistan,58.73,HUB > BREATHE,1.1.7,cf190350-74c6-45f2-8ede-69ace62eb88d,8fc0a2cc-a8ce-4558-a98a-c514255833d8,Bronze,77.55
71.42,34.88,Bronze,38.1,73.81,Covid-19 Infection Survey,80.95,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,628e9ad9-28c5-4d58-9ec5-04a63be9b4cf,90ad6023-6c7f-4605-9323-b478a27c3c9a,Bronze,69.47
71.43,20.93,Bronze,20.63,71.43,Bloodwise Childhood Leukaemia Cell Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,93baeb13-cc4b-47fd-9dae-5ae5277cba54,914321d0-1d86-4974-a38d-97469f9ff2cd,Bronze,75.25
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): Pulmonary rehabilitation - organisational audit,22.22,ALLIANCE > HQIP,1.1.7,4b33fc6d-3cac-4404-adac-d693328456fa,91479cbf-664e-4782-8514-a3247bb5c4f4,Not Rated,45.66
80.16,25.58,Silver,31.75,85.71,National Records of Scotland (NRS) - Stillbirth Data,92.06,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,dca0c95b-ae7d-4163-8c3b-a881f779df02,92490df7-466b-4cd8-af4f-4528ed21d203,Silver,80.06
45.23,30.23,Not Rated,31.75,26.19,National Diabetes Audit - Core Clinical Audit Dataset,22.22,ALLIANCE > HQIP,1.1.7,f4c8900b-5db5-4426-95e9-2f1617c92a76,92d95f82-50a5-4df9-914a-ca26b14cf84c,Not Rated,47.98
80.95,27.91,Silver,34.92,92.86,Yorkshire Specialist Register of Cancer in Children and Young People,96.83,HUB > DATA-CAN,1.1.7,93582beb-e45a-47b6-aeab-d26f583e4c3b,931efe47-04eb-4ff3-aa62-97e2e4007aed,Silver,82.47
86.51,23.26,Silver,26.98,95.24,National Survey for Wales,100.0,ALLIANCE > SAIL,1.1.7,bcca421a-9077-4c47-9daa-b1bc030d3dee,9360bc6c-2a7d-4415-869d-3e853c558f4d,Gold,85.99
47.62,46.51,Not Rated,50.79,35.71,Demography,46.03,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,b88c2b24-b75d-4d28-9391-2dbac1605a17,93ad5a26-65f5-438f-b4e3-9f7078cc2f92,Not Rated,44.6
54.76,27.91,Not Rated,25.4,38.1,Imaging,34.92,UK Biobank,1.1.7,32a2dcb1-1e18-44ba-ad49-b3da312ca447,93d26255-7199-4ea7-997d-f74890d12b87,Not Rated,55.09
69.05,23.26,Bronze,22.22,69.05,National Unified Renal Translational Research Enterprise (NURTuRE),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,15f07cef-f4cc-4a50-90bc-9fd40f8b6327,9445e723-655a-43d0-a4e5-50313d98eac0,Bronze,72.89
69.84,20.93,Bronze,20.63,69.05,BioDock,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,ecb82441-286f-408d-880c-9239a25fb5cd,94e28efd-a976-4748-81fd-956a598c26cb,Bronze,74.06
71.43,20.93,Bronze,20.63,71.43,RAPPER,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,76d26f0f-0136-4ae5-8be9-37782a70bac5,94fab6d3-9753-4ffd-ade2-02d199d93f94,Bronze,75.25
55.55,51.16,Not Rated,52.38,50.0,Mental Health Dataset (MHDS) for CPRD GOLD,63.49,ALLIANCE > CPRD,1.1.7,d5c0cc93-3347-46f0-b8dd-f44e82718e38,95475a1f-1623-4bfa-9821-1159d4dbcc8e,Not Rated,49.42
67.46,32.56,Not Rated,34.92,59.52,VIVALDI 2,69.84,OTHER > UNIVERSITY COLLEGE LONDON,1.1.7,12f1ffbc-0ddd-4d6e-b126-2cccf6738658,96c73136-da1b-43de-9fd1-9d5e63631b14,Bronze,63.48
61.11,48.84,Not Rated,47.62,54.76,Pregnancy Register for CPRD GOLD,69.84,ALLIANCE > CPRD,1.1.7,14aaf184-5922-4459-affb-6c9e55c12176,96d29a1d-9566-4793-8dbb-351fbe2eb790,Not Rated,52.96
80.96,27.91,Silver,28.57,83.33,SAIL Dementia e-Cohort,90.48,ALLIANCE > SAIL,1.1.7,f48b7c05-6a44-480c-84c6-4f7a684f29f8,9709ee81-c5f1-4c01-a1ac-51ae2a0a60f3,Silver,77.71
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,eab996ed-b268-439a-bff4-19925698336a,97fa09e6-5ea5-41cd-baf8-20366db13a3f,Not Rated,56.57
57.94,48.84,Not Rated,44.44,47.62,Quality of Life of Cancer Survivors in England: Pilot Patient Reported Outcomes Measures Survey (2011) for CPRD GOLD,60.32,ALLIANCE > CPRD,1.1.7,4b1da116-44a5-4952-a09e-deb0d37af2f2,992c8fe6-f460-490c-b202-8d4d9c434425,Not Rated,49.39
70.64,23.26,Bronze,22.22,73.81,RATHL Trial,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,e5ec63dd-4da5-4119-99c8-5cc79045618c,99812cec-ea1c-4979-8e00-32df5bad000b,Bronze,75.28
44.45,32.56,Not Rated,33.33,26.19,National Bowel Cancer Audit - clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,c8a28f0b-a5f8-4dbb-8d71-5b89c7cb3111,9a4ef776-6b4b-40cd-9c88-cbf1128780e9,Not Rated,46.81
58.73,46.51,Not Rated,42.86,47.62,Cancer Patient Experience Survey (CPES) for CPRD GOLD,60.32,ALLIANCE > CPRD,1.1.7,a4ecb8df-c72f-4018-8f23-e180c28dfdb6,9a58219f-8cea-479c-bb5f-c68cae23136b,Not Rated,50.55
78.57,23.26,Silver,28.57,80.95,COVID-19 Clinical Information Network (CO-CIN),85.71,ALLIANCE > ISARIC 4C,1.1.7,84336be3-23bd-466e-b29b-df48db897665,9a85b69e-fd3e-4522-bc68-48024df0ea3e,Silver,78.84
74.6,30.23,Bronze,34.92,78.57,Coronavirus and the social impacts on Great Britain,84.13,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,e253257c-48c2-491b-b3b9-205161a16a7e,9ad4cc56-e86f-4d96-a515-05ee37edc1e9,Bronze,74.17
54.76,39.53,Not Rated,36.51,47.62,Mental Health Services Data Set - Currencies,46.03,ALLIANCE > NHS DIGITAL,1.1.7,add485fa-4c54-4a3e-8676-abe2ff4725a5,9b7f7994-0b9c-4809-b67d-45ae1f04ec5c,Not Rated,54.05
65.08,39.53,Not Rated,41.27,61.9,HES Patient Reported Outcomes Measures (PROMs) data for CPRD GOLD,71.43,ALLIANCE > CPRD,1.1.7,2439a88e-d961-4152-a7b5-042097946209,9bc66d1b-68a2-4d4e-a54a-cc3842ff95c7,Not Rated,61.19
41.27,37.21,Not Rated,38.1,23.81,National Asthma and COPD Audit Programme (NACAP):COPD and adult asthma secondary care organisational dataset,20.63,ALLIANCE > HQIP,1.1.7,1982d9ef-890a-41ff-a86a-de61d65aaa09,9beca627-12cd-4231-8638-93cf0bdfa413,Not Rated,43.3
74.6,34.88,Bronze,36.51,78.57,PHM and Cancer Outcomes in the WYH Cancer Alliance,85.71,HUB > DATA-CAN,1.1.7,bc839e9c-e303-4c3c-9c2c-9975602376e2,9bfba8a4-43c3-4356-93a5-3eb3b7bc247a,Bronze,71.84
42.86,34.88,Not Rated,36.51,26.19,Falls and Fragility Fracture Audit Programme National Hip Database clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,e06b951b-e9d8-4a2c-a51f-1d819f669205,9c0f13ca-5831-4d9b-860a-7d856be7a9f1,Not Rated,45.66
88.09,20.93,Gold,23.81,95.24,"Extended Cohort for E-health, Environment and DNA (EXCEED)",100.0,HUB > BREATHE,1.1.7,e22ddf52-7f9e-4072-ae61-cb722461b37d,9ca6e8d2-98d2-4757-84e1-287585400e55,Gold,87.16
40.48,37.21,Not Rated,36.51,21.43,Tayside Pathology,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,419e5a82-2d82-48a7-a8f3-a83e64a54e92,9ce35921-a1de-444b-a822-c0f6a8003797,Not Rated,42.11
83.34,25.58,Silver,28.57,90.48,IBD NIHR BioResource: Sample holding,95.24,HUB > GUT REACTION,1.1.7,f2af20f9-af84-40ce-8a07-7d095948653e,9d4f445e-f81e-45d7-bd83-7e9f68199b4f,Silver,82.45
43.65,32.56,Not Rated,34.92,26.19,National Early Inflammatory Arthritis Audit - patient survey,22.22,ALLIANCE > HQIP,1.1.7,e87410ec-a819-43db-99d1-f887c977e525,a05443cd-e292-4b5f-b1f1-95718e300d46,Not Rated,46.81
69.84,20.93,Bronze,20.63,69.05,UK CLL Trials Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,636e216a-072b-4c8b-b867-23b7666d2cb2,a06afa88-caba-4354-ac70-d05c67b34dfc,Bronze,74.06
56.34,51.16,Not Rated,49.21,50.0,Cancer registration data for CPRD GOLD,61.9,ALLIANCE > CPRD,1.1.7,e2f5d637-94b3-447b-b7eb-ea957ce449b6,a0dad23c-c02d-4347-92ef-0019fa59eb3e,Not Rated,49.42
69.84,51.16,Bronze,58.73,92.86,HIC Transplantation,98.41,NIHR Health Informatics Collaborative Renal Transplantation Theme,1.1.7,359a322e-3781-4796-b6b2-81962fa19b7a,a0e0c0c2-072a-47ac-9252-e27b37ac024f,Bronze,70.85
54.76,27.91,Not Rated,25.4,38.1,Biological sample assays,34.92,UK Biobank,1.1.7,14c697a5-2d41-4d86-bf17-2e596d07418b,a11a234b-8b59-41e8-920a-f8f1799d3c77,Not Rated,55.09
73.02,34.88,Bronze,39.68,78.57,NIHR BioResource: Case report form,85.71,ALLIANCE > NIHR BIORESOURCE,1.1.7,4b8675d3-dd87-4cca-804c-aaf0e4ff8140,a182b27f-5000-40f0-8afd-f2f193a31b7d,Bronze,71.84
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,7b31b427-b447-432e-9a6c-ad2099343491,a1a67182-e81b-4144-ac51-92a86f277eb2,Not Rated,56.57
89.69,18.6,Gold,20.63,95.24,Brecon dataset,100.0,ALLIANCE > SAIL,1.1.7,9c6e891f-6449-48d2-a1c3-8dd236e34bbd,a1e1ec62-d78c-40ac-9f90-66ef1dd865b2,Gold,88.32
71.42,34.88,Bronze,38.1,73.81,Death registration data - Provisional Monthly Extracts,80.95,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,487222b7-5c13-4a92-8b41-044796048720,a28cf3ca-8bad-45bb-bca0-78b4d22fed69,Bronze,69.47
85.72,23.26,Silver,28.57,95.24,Comprehensive Patient Records for Cancer Outcomes,100.0,HUB > DATA-CAN,1.1.7,ce4582a8-0985-46c6-b95f-29a5de862d4a,a337845e-1dde-445b-90cf-91d8b825e3a5,Silver,85.99
71.43,32.56,Bronze,41.27,76.19,ECOSS (-/+VE tested patients only),84.13,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,5542cadc-11a4-4957-bbdd-8a6c46bcfb87,a3b9cfd3-abd1-4d18-99cc-360cd9d543c2,Bronze,71.81
89.69,18.6,Gold,20.63,95.24,Care Home Dataset,100.0,ALLIANCE > SAIL,1.1.7,aae02f9e-1bad-415d-9730-c46a07a990aa,a45acd02-82d7-4bfe-9845-6b4df683bba8,Gold,88.32
71.43,20.93,Bronze,20.63,71.43,UK ME/CFS Biobank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,d0694e15-b6ba-4a95-962a-dbf627ca207c,a5163bce-7c03-4e61-8ebc-024939c047a8,Bronze,75.25
44.45,34.88,Not Rated,34.92,28.57,The Primary-Secondary Care Partnership to Improve Outcomes in Chronic Kidney Disease,23.81,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,1.1.7,d472a895-8587-4503-956e-3bd66d990979,a5c088cd-dae6-4c58-b381-a0d273585f4d,Not Rated,46.84
65.87,32.56,Not Rated,36.51,59.52,Sars-CoV-2 Immunity & REinfection EvaluatioN (SIREN),68.25,ALLIANCE > PUBLIC HEALTH ENGLAND,1.1.7,8e0221d4-dcfa-4580-834b-f44421fca3b5,a638f8a0-3527-49a8-a269-06db49f051c6,Not Rated,63.48
69.05,23.26,Bronze,22.22,69.05,plasmaMATCH,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,5618f65d-23fc-4bd5-9a4c-73e4b330c3a6,a6472a29-17db-477c-bb6e-264686c8fc26,Bronze,72.89
37.3,39.53,Not Rated,39.68,16.67,LIMS,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,df70b490-3c00-458e-a6dd-ea3242a3ebac,a74f72ad-bf70-42e4-8933-069c7b53c7f9,Not Rated,38.57
57.14,51.16,Not Rated,49.21,50.0,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,c84192af-a477-4ed5-a95b-c88e1f98ce1b,a772b8dd-cb93-4f27-a349-329992e0b212,Not Rated,49.42
88.89,20.93,Gold,22.22,95.24,GP dataset - Welsh Primary Care,100.0,ALLIANCE > SAIL,1.1.7,33fc3ffd-aa4c-4a16-a32f-0c900aaea3d2,a79dbdef-eac1-49d7-9fdb-150ed5340481,Gold,87.16
85.72,20.93,Gold,28.57,95.24,HDR UK Papers & Preprints,100.0,OTHER > HEALTH DATA RESEARCH UK,1.1.7,fd8d0743-344a-4758-bb97-f8ad84a37357,a7ddefbd-31d9-4703-a738-256e4689f76a,Silver,87.16
70.63,11.63,Bronze,12.7,61.9,Scottish Immunisation Recall System (SIRS),53.97,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,c027d0ca-7c7d-4864-b4dd-8040f4020fbb,a807ff6d-bdcd-4649-a9d2-b7bc6dfb9a5b,Bronze,75.14
42.86,34.88,Not Rated,36.51,26.19,National Asthma and COPD Audit Programme (NACAP): primary care workstream resources,22.22,ALLIANCE > HQIP,1.1.7,8a3ec96a-0600-4c6d-8761-9d277f07b9da,a895be78-f41c-40b8-b2fa-678a071a6427,Not Rated,45.66
65.08,25.58,Bronze,25.4,61.9,Salford Lung Study,55.56,HUB > BREATHE,1.1.7,86838cad-d5d3-4b65-9c37-29b0c8c36309,a8f5117e-7523-452f-abf3-ced72f03cb2e,Not Rated,68.16
83.34,23.26,Silver,23.81,83.33,Scottish Cancer Registry (SMR06),90.48,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,ad36dc03-1856-44de-99b0-1af6f312d86b,a971ac7b-04e5-4bd5-8bfa-b456d5ed4dbf,Silver,80.03
77.78,27.91,Bronze,26.98,73.81,"Demography, interventions & outcomes of patients with Cerebrovascular Disease",82.54,HUB > PIONEER,1.1.7,ddf7f82f-b453-442d-b562-bb0157593831,a9b50e33-9974-4635-8e52-9c9b3cb87eb2,Silver,72.95
84.13,25.58,Silver,28.57,92.86,North West London Primary Care Events Data (NWL PCE),96.83,HUB > DISCOVER NOW,1.1.7,0f930154-0a0e-4bef-9464-59e657b904d6,a9f4a852-a1f2-4041-bb33-3a50e6c43f8d,Silver,83.64
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v3_3.5 (Non-Sensitive),77.78,ALLIANCE > NHS DIGITAL,1.1.7,348b12fb-7718-477e-a572-4fc3c716152d,aa019da2-0f2f-493c-95e8-7263ee735f46,Not Rated,56.57
40.48,37.21,Not Rated,36.51,21.43,Fife Microbiology: Tests,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,0c43c0b6-de3a-478b-8190-4da37fbe5ff5,aa5c8e81-ad02-4366-9577-472f7ed339d9,Not Rated,42.11
69.84,37.21,Not Rated,38.1,69.05,HES Diagnostic Imaging Dataset for CPRD GOLD,77.78,ALLIANCE > CPRD,1.1.7,a1bef3a6-9700-43a5-8f3e-dad44ce1fe10,aa8c53e8-f91f-41f7-9522-7e2462a9a84b,Bronze,65.92
64.28,46.51,Not Rated,46.03,61.9,Mental Health Minimum Data Set,74.6,ALLIANCE > NHS DIGITAL,1.1.7,285ae0ae-196b-4a75-b1f1-78b07162acfa,acafb160-b18a-436e-90f1-dc4530a90267,Not Rated,57.7
54.77,25.58,Not Rated,26.98,42.86,Covid Immunisation,36.51,NCS > OFFICE FOR NATIONAL STATISTICS,1.1.7,e1a6c1e1-1cec-49cd-aea0-37d4ff56435d,acd433ab-51a7-445b-8700-fbce57d82a29,Not Rated,58.64
81.75,25.58,Silver,28.57,88.1,IBD NIHR BioResource: Contact detail,92.06,HUB > GUT REACTION,1.1.7,02ddc5c9-03d4-40e4-9934-e60817ec8f3e,ad638da8-366b-481f-995e-fc326301eb16,Silver,81.26
69.84,20.93,Bronze,20.63,69.05,Cardiff School of Dentistry Tooth Bank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,0d4f0103-82d8-43f4-8058-4aec80ea562f,adbee090-9634-455e-9be1-62843158fb08,Bronze,74.06
84.13,25.58,Silver,28.57,92.86,North West London Admitted Patient Care Data (NWL APC),96.83,HUB > DISCOVER NOW,1.1.7,788857b5-6a5b-4ec2-825e-d965e291cf45,adce90ad-d576-4c98-9de9-dca19f7f4d41,Silver,83.64
69.84,20.93,Bronze,20.63,69.05,Biobank for patients with retinal degenerations & dystrophies,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,cee932f8-151c-4834-ac6d-61d842f9d170,ae2022bc-2083-4e57-b825-1fb610d910ee,Bronze,74.06
57.94,23.26,Not Rated,25.4,50.0,Optimum Patient Care Research Database,41.27,HUB > BREATHE,1.1.7,e3ca35c1-b2e2-4479-adf1-6a78b1c8c088,ae4b8371-d037-46e8-bdcd-bf3de08ef38e,Not Rated,63.37
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient NTM culture,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,69bdac5f-bb70-4ca5-a5ce-51a6106ad00b,ae788191-69e5-4a03-b11b-bd25574b0e4f,Silver,83.66
37.3,41.86,Not Rated,41.27,19.05,Community Services Dataset,15.87,ALLIANCE > BARTS HEALTH,1.1.7,cae0a9a5-1bf2-49c3-b8d1-c315d3239074,ae9e8a9f-533f-4823-8e00-84e39ad2c266,Not Rated,38.59
45.23,30.23,Not Rated,31.75,26.19,National Audit of Care at the End of Life - Quality Survey,22.22,ALLIANCE > HQIP,1.1.7,51a8dfba-5c94-48bd-9c68-3707f0ebc2a2,aeb2f1ea-c914-4b30-94c8-9fd3eb51b288,Not Rated,47.98
67.47,18.6,Bronze,20.63,64.29,Community perception on public health measures for COVID-19 prevention/control,55.56,HUB > BREATHE,1.1.7,6464fb4f-2838-495b-9963-4001204ed166,af238430-c257-4d60-9ff0-1de6b825f09e,Bronze,72.84
71.43,20.93,Bronze,20.63,71.43,Manchester Cancer Research Centre (MCRC) Biobank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,095d805c-4b62-4726-b968-bb2f1c463701,af2b3e6d-718e-464a-8c0d-5882fa1d869f,Bronze,75.25
71.43,20.93,Bronze,20.63,71.43,Cardiff University Biobank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,097540aa-a0ed-492e-853b-9ebcfd061dea,af2ecff2-398c-437f-8c45-adef2406ce43,Bronze,75.25
69.84,20.93,Bronze,20.63,69.05,NIHR Exeter Clinical Research Facility,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,df9b7bb1-1b26-4e67-b885-df2dcb8e3450,af4af5cc-a9eb-4e0e-b50a-3cab4ac2daf9,Bronze,74.06
86.51,18.6,Silver,22.22,90.48,National Neonatal Research Database,95.24,ALLIANCE > NEONATAL DATA ANALYSIS UNIT - IMPERIAL COLLEGE LONDON,1.1.7,67020745-9def-4c6e-b5ac-bb273bd0a20e,afc8af43-d6cd-4faa-b204-8fc471119b98,Gold,85.94
39.68,39.53,Not Rated,38.1,21.43,Tayside Radiology,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,af10ec29-1866-4726-b33f-3948afe182f2,b1dc1917-8522-4ecd-a829-c866c5cffe3b,Not Rated,40.95
54.76,27.91,Not Rated,25.4,38.1,Primary-care data,34.92,UK Biobank,1.1.7,439e71c7-33b5-4e85-98ce-4b068f2523ad,b27afede-a51d-4aae-8bf7-ce94888fe898,Not Rated,55.09
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Transplants,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,bea354e8-c552-41ef-80c2-a76ca5767e4b,b2fb79c5-26db-484b-8e93-1c56d7654f57,Silver,83.66
73.81,46.51,Bronze,52.38,95.24,HIC ICU 8.3.2,100.0,NIHR Health Informatics Collaborative Critical Care Theme,1.1.7,4f546f1e-433c-4884-a090-2a4520c878ac,b40777a2-468b-4b45-8b7d-2f62f912e950,Bronze,74.36
76.19,30.23,Bronze,36.51,80.95,UK Cystic Fibrosis Registry (CYFI),88.89,ALLIANCE > SAIL,1.1.7,0628fb77-057d-4838-b80e-18245a8f535d,b43309eb-7860-49b7-9f11-1a7a0fd5532e,Silver,75.36
56.35,48.84,Not Rated,47.62,47.62,Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum,60.32,ALLIANCE > CPRD,1.1.7,f8af632e-442d-4931-a370-b7fa2fa4b896,b4f6a5c2-e652-4972-9d06-510e9a469dfe,Not Rated,49.39
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Chronic Medication,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,0ad31772-0893-4cf7-bab0-683e80302201,b5033be2-0744-49c5-a398-a4d3ed4e1deb,Silver,83.66
59.52,51.16,Not Rated,55.56,61.9,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Episodes,74.6,ALLIANCE > NHS DIGITAL,1.1.7,ef22c16c-c294-46e1-abf9-5204212e9053,b53f716d-a5c3-4ad8-a2aa-cae09c12ac18,Not Rated,55.37
80.16,30.23,Silver,30.16,83.33,Radiotherapy Dataset,90.48,ALLIANCE > SAIL,1.1.7,f102ca50-d1e4-44ec-924e-be89446652af,b589b19b-b43f-4344-affb-5d7ea328c909,Silver,76.55
89.69,18.6,Gold,20.63,95.24,Cafcass England,100.0,ALLIANCE > SAIL,1.1.7,8ee61578-e298-423a-be22-cb0438023e5c,b70900e9-85e9-4dd2-ae4b-02523be4219d,Gold,88.32
89.69,18.6,Gold,20.63,95.24,Welsh Demographic Service (WDS),100.0,ALLIANCE > SAIL,1.1.7,8a8a5e90-b0c6-4839-bcd2-c69e6e8dca6d,b724a905-e8ae-4ab5-b543-91435f8d3514,Gold,88.32
69.84,20.93,Bronze,20.63,69.05,Public Health England Seroepidemiology Unit,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,89497432-17e0-49f4-96a4-65ef57d07701,b7a352ee-6306-4bd8-b9bc-f2a69fe17d70,Bronze,74.06
88.89,18.6,Gold,20.63,92.86,Welsh Ambulance Services NHS Trust,98.41,ALLIANCE > SAIL,1.1.7,d415a5c5-8432-4a81-937f-12135ade6de7,b8e0b4a8-aab6-47fc-ac6f-76cd5cdc933d,Gold,87.13
69.05,23.26,Bronze,22.22,69.05,ESPAC-TPlus,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,47f979bc-da9d-4e9e-9f2b-15e09366db04,b9642fb3-3bee-491b-8d83-22f9de0fd77f,Bronze,72.89
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Non-Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,3adeb2f4-a924-49cb-9537-84a9a4242a62,ba071b0b-5ef4-457b-b194-3a69c2c71a06,Not Rated,56.57
66.67,18.6,Bronze,20.63,61.9,Assessment of ASHA’s workload and its determinants,53.97,HUB > BREATHE,1.1.7,1a02bc11-a378-4f9e-82f9-c52674b388bd,bab944af-e345-4893-8640-a88aaff97c72,Bronze,71.65
60.31,46.51,Not Rated,42.86,50.0,Patient postcode linked deprivation measures for CPRD GOLD,63.49,ALLIANCE > CPRD,1.1.7,f5c9ba01-a9cb-4a85-9850-d9466b2ff4fb,bc6ae5bc-7175-49e2-b093-337dde427736,Not Rated,51.75
57.14,23.26,Not Rated,22.22,40.48,UK Biobank Assessment Centre,36.51,UK Biobank,1.1.7,2775b97f-1606-490e-81ef-35bad050434a,bcb224fe-592f-4aaf-abd1-ad3e3caa61ff,Not Rated,58.61
87.3,20.93,Gold,25.4,95.24,Emergency Department Data Set,100.0,ALLIANCE > SAIL,1.1.7,75c4dcb8-33bf-43f4-b2bb-db51b6621b2c,bd2d56db-f24b-4ac6-9201-3d68c65472b5,Gold,87.16
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,3d348613-2d66-4814-a294-7e0c365f43f8,bdc17b2c-8b0f-4959-ab9b-e2de32d8a5f9,Not Rated,56.57
61.11,48.84,Not Rated,47.62,54.76,Mother-Baby Link for CPRD GOLD,69.84,ALLIANCE > CPRD,1.1.7,b734a1b5-37d3-4859-85d4-bf011df2a951,bdcbbb2b-df99-4ae7-b36e-f266cfe10ed3,Not Rated,52.96
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Revision Shoulder Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,9623e62b-3c50-44aa-8923-0bbb94e7ad61,bddcc89d-028f-48a5-b568-7dccd574563b,Not Rated,47.98
65.87,32.56,Not Rated,36.51,59.52,Oxford Healthcare Workers,68.25,ALLIANCE > OXFORD UNIVERSITY HOSPITALS,1.1.7,9de2f365-4c5d-4252-acee-6270b113aa93,be1368c6-c97f-4ce0-8322-f97ccb28b9c3,Not Rated,63.48
68.25,23.26,Bronze,23.81,69.05,Barts CTU,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,22aa219f-f3c8-4a25-822e-aa2504f6f29a,be77a483-2eff-4c05-8091-035fe79b3c8a,Bronze,72.89
69.84,16.28,Silver,19.05,69.05,4 LMIC Asian Country ChrOnic: estimating respiratory disease burden in adults,58.73,HUB > BREATHE,1.1.7,490747bf-b268-41f3-8f35-f6bc4a4bdbfa,be9bf427-d96d-4b1a-b1d1-83bdc3e8790b,Bronze,76.38
62.7,23.26,Bronze,23.81,59.52,NIHR BioResource: Metabolite data,49.21,ALLIANCE > NIHR BIORESOURCE,1.1.7,dec09f2e-a93f-41e2-8217-72431ea4a19e,bf083b35-da74-4b82-87d3-203ba60325c6,Not Rated,68.13
55.55,25.58,Not Rated,23.81,38.1,Online questionnaires,34.92,UK Biobank,1.1.7,8ef26f38-d1b3-4b24-b80a-717f216c6aea,bf625cfe-c4b2-4ea8-bbe8-1a8873ca4cb9,Not Rated,56.26
36.51,41.86,Not Rated,41.27,16.67,TheatreEvents,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,2c6adf80-f30b-46c9-b9d4-fe3e68622469,bf83ada4-b72e-4789-b177-12a53aa763ea,Not Rated,37.41
70.64,23.26,Bronze,22.22,71.43,Daisy Tumour Bank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,b3ec5c18-e339-4bd8-8a59-5a3445a81f16,c03468f4-ba51-4d9f-a785-f041adb84724,Bronze,74.09
45.24,30.23,Not Rated,33.33,28.57,Vitamin D supplementation meta-analyses,23.81,HUB > BREATHE,1.1.7,2454a964-be58-4d1f-8f9a-ffae9db9129c,c16605d7-6e6e-4461-bfab-107660e31427,Not Rated,49.17
76.19,32.56,Bronze,33.33,78.57,Hospital Episode Statistics Admitted Patient Care,85.71,ALLIANCE > NHS DIGITAL,1.1.7,2b6409db-a669-4bef-9fd5-39c2b6f8d5e9,c168178a-143b-402b-9ab4-2f230cf06226,Silver,73.0
84.12,25.58,Silver,31.75,95.24,Cystic Fibrosis Patient Demographics,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,19bc55c2-13d7-4488-a52c-35287483ea4e,c1682cb7-8f43-49fa-b66a-0a4a205885d3,Silver,84.83
68.25,18.6,Bronze,20.63,66.67,Assessing the eDPSEEA model in seasonal pollen induced asthma in Islamabad,57.14,HUB > BREATHE,1.1.7,bfa012ad-e609-4d15-a824-6d143758ca4d,c2548017-7913-40e1-bf98-aaa2e907b0ea,Bronze,74.03
69.05,23.26,Bronze,22.22,69.05,NICAM: Nilotinib treatment for c-KIT mutated advanced AMM,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,ba0edcaf-854d-4907-851a-280b56128b3b,c2c77d1a-d4d8-40cd-95f3-31912d4bd561,Bronze,72.89
87.3,20.93,Gold,25.4,95.24,Outpatient Referral,100.0,ALLIANCE > SAIL,1.1.7,7465c65e-c321-42e9-a2f4-6bc664caf1fc,c2ddca9f-f144-437b-ac7a-0a628a50ba1a,Gold,87.16
77.78,30.23,Bronze,31.75,80.95,National Diabetes Audit,87.3,ALLIANCE > NHS DIGITAL,1.1.7,9a434a5c-563b-4da1-9133-9994960ade54,c2e112a0-a198-46b0-9a0c-ec91edfb6839,Silver,75.36
82.54,16.28,Silver,17.46,76.19,Child Health Systems Programme - 4-5 year review,82.54,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,5844bde6-628d-4e76-bb56-3534e2728eb6,c2ebe992-e9e8-4316-a565-20d312aa9ef7,Silver,79.95
70.64,23.26,Bronze,22.22,71.43,TRICON8,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,85113a93-89ed-40e3-a479-33b461b91858,c3b4f4f2-953e-4470-bedd-9d09fd30a508,Bronze,74.09
43.65,32.56,Not Rated,34.92,26.19,Sentinel Stroke National Audit Programme Acute Organisational survey dataset,22.22,ALLIANCE > HQIP,1.1.7,fe6a4c83-f46f-4f61-8460-e120fdf8d864,c3d84dfa-fe3a-4b86-a0f5-efbe45aa93ad,Not Rated,46.81
76.19,32.56,Bronze,33.33,78.57,Hospital Episode Statistics Critical Care,85.71,ALLIANCE > NHS DIGITAL,1.1.7,80564a6b-1458-41de-a131-772eb93c0509,c476d414-8397-48a3-a0b3-95236b0c3515,Silver,73.0
69.84,37.21,Not Rated,38.1,69.05,HES Accident and Emergency data for CPRD GOLD,77.78,ALLIANCE > CPRD,1.1.7,733b1060-f958-4c3e-ab6a-2b87901d9a9a,c55b92d8-889d-435c-b0cb-2d9f7b432839,Bronze,65.92
69.05,39.53,Not Rated,39.68,69.05,Death Registration data for CPRD Aurum,77.78,ALLIANCE > CPRD,1.1.7,ad8f07ef-a984-449b-8a60-d1dd564cc36d,c577669a-a84f-493e-8164-3fe02f618561,Bronze,64.76
44.45,32.56,Not Rated,33.33,26.19,National Audit of Psychosis - Audit on Early Intervention in Psychosis services - contextual data,22.22,ALLIANCE > HQIP,1.1.7,4559a14f-563d-4fd2-93ae-27c6c0fd891e,c5994fae-9c4a-47eb-ba42-85bd76e92879,Not Rated,46.81
60.31,46.51,Not Rated,42.86,50.0,Practice postcode linked deprivation measures for CPRD GOLD,63.49,ALLIANCE > CPRD,1.1.7,3326d554-ca11-4dc6-aff0-c5b314442d27,c6117afd-bc4d-404b-8d58-9d87db936b4c,Not Rated,51.75
65.08,32.56,Not Rated,36.51,57.14,PANTHER study,66.67,ALLIANCE > UNIVERSITY OF NOTTINGHAM,1.1.7,596077a9-298b-44cc-aa7a-81f04cf5dcb3,c66f943f-4307-4486-817c-49f6d8b9fd6b,Not Rated,62.29
61.11,51.16,Not Rated,55.56,64.29,Mental Health & Learning Disabilities Dataset v 1 (Non-Sensitive) Episodes,77.78,ALLIANCE > NHS DIGITAL,1.1.7,334afc50-a05a-43b9-aa1e-a012a22733e0,c713773c-e961-400e-b44a-947002deb073,Not Rated,56.57
71.43,25.58,Bronze,23.81,76.19,SCOT translational sample collection,66.67,ALLIANCE > TISSUE DIRECTORY,1.1.7,b3b790a7-a455-4efb-9c68-60e7131cb836,c78122ae-8be1-40d7-8567-b83059941c16,Bronze,75.31
87.3,20.93,Gold,25.4,95.24,COVID-19 Consolidated Deaths,100.0,ALLIANCE > SAIL,1.1.7,70e37f44-5c3e-4c83-a42a-89b3476d1d45,c809126e-315b-4bcc-8fa3-741317bf9a4e,Gold,87.16
40.48,37.21,Not Rated,36.51,21.43,Tayside Microbiology: Tests,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,826be5be-9977-49f9-b6d1-83ed9de08ebe,c8516bb0-e4c5-484f-a370-f49315e3a330,Not Rated,42.11
69.84,20.93,Bronze,20.63,69.05,National Diet and Nutrition Survey (NDNS),60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,f86400cb-7cab-4e34-aab6-57138b6a96c2,c960ffab-a94c-45e3-96a0-598719acfbf5,Bronze,74.06
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4.1 (Non-Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,01c88a30-b14d-401e-82bb-165cbde81942,c97b8058-a6a4-4c8d-92e1-6e9f4cddd301,Not Rated,56.57
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Annual Review Encounters,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,11360490-8da3-4a25-bb87-4fcc249b9af5,ca2c6ec0-00ce-42fc-a077-88911259576c,Silver,83.66
81.75,27.91,Silver,36.51,95.24,Cystic Fibrosis Patient Liver Enzyme,100.0,ALLIANCE > CYSTIC FIBROSIS TRUST,1.1.7,f72e80fc-dcd3-4457-ae91-dd14449002dd,caa644b6-a50d-455b-bee1-96232443e2b9,Silver,83.66
45.23,30.23,Not Rated,31.75,26.19,National Audit of Care at the End of Life - case note review,22.22,ALLIANCE > HQIP,1.1.7,d8c67899-2d81-48c2-8482-31cd33973a36,cabb1db1-ee3e-42ce-a40b-468282e2011d,Not Rated,47.98
37.3,41.86,Not Rated,41.27,19.05,Critical Care Minimum Dataset,15.87,ALLIANCE > BARTS HEALTH,1.1.7,c71fbdc3-0311-4b3f-a9ff-7d2f2c0ba993,cb020c3c-f738-4741-bf6b-3df16611b02e,Not Rated,38.59
69.84,23.26,Bronze,23.81,71.43,UKCTOCS Longitudinal Women's Cohort (UKLWC),63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,e0b951ba-0f7d-4743-9374-b965042accdd,cb7370a6-a1b0-4473-a32f-ec85ec0155a5,Bronze,74.09
43.65,32.56,Not Rated,34.92,26.19,National Early Inflammatory Arthritis Audit - organisational survey dataset,22.22,ALLIANCE > HQIP,1.1.7,a9ac99fe-32be-40ef-9509-03e6b2713ddf,cbda5643-96b7-4914-b990-a872e693ff29,Not Rated,46.81
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4.1 (Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,c00d5ad2-d5d2-4318-8849-4c2fe52aabd0,cc383a3f-1c47-4b7d-99cf-be8ee0afe401,Not Rated,56.57
69.84,39.53,Not Rated,39.68,71.43,HES Admitted Patient Care data for CPRD Aurum,79.37,ALLIANCE > CPRD,1.1.7,ed2de8fe-a204-4a4e-bcfa-9e3ad85e2fee,cc3e20da-aca5-471d-a4bb-38e13f350f10,Bronze,65.95
71.43,23.26,Bronze,22.22,73.81,National Cancer Registration Dataset 2018,65.08,ALLIANCE > PUBLIC HEALTH ENGLAND,1.1.7,267e13c1-d857-4702-853a-71abc34e6287,cd0cc1de-f0bc-4247-9e67-47e162e2cc6b,Bronze,75.28
69.84,25.58,Bronze,23.81,73.81,RIO,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,18bc81e3-7d99-4152-bd7a-3c90ee7e489d,cde234d0-748b-4df6-a59d-3268cc7e8c1d,Bronze,74.12
86.5,20.93,Silver,25.4,92.86,Postponed Admitted Procedures,98.41,ALLIANCE > SAIL,1.1.7,bff94600-a254-4111-82f7-6167084d81ca,ce192e2e-4f31-4bb0-9c1f-5c4173c03011,Gold,85.97
37.3,41.86,Not Rated,41.27,19.05,Maternity Services Dataset,15.87,ALLIANCE > BARTS HEALTH,1.1.7,173d07ab-5930-4d19-b3de-dcca193e62fd,ce1bcddb-a6af-4511-84c6-2a252d3eb202,Not Rated,38.59
81.75,27.91,Silver,33.33,92.86,North West London Community Data (NWL COM),96.83,HUB > DISCOVER NOW,1.1.7,65dad445-ed81-4005-9f5a-4f8a7164043e,ce896b89-5f4a-407c-bb10-7eec51089458,Silver,82.47
55.56,27.91,Not Rated,26.98,42.86,Improving Access to Psychological Therapies Data Set,38.1,ALLIANCE > NHS DIGITAL,1.1.7,bcf6e5ce-986d-4b84-9c9c-69de966e8bbd,cef00323-8756-4ea5-99e4-f12dcb2c6297,Not Rated,57.48
44.45,32.56,Not Rated,33.33,26.19,National Clinical Audit of Anxiety and Depression - spotlight audit on psychological therapies (clinical),22.22,ALLIANCE > HQIP,1.1.7,6c81b082-bdc5-4dcc-838a-e6e52e1be1cb,cf3f4336-e52d-4b82-8cc5-647dedaaee57,Not Rated,46.81
57.14,51.16,Not Rated,49.21,50.0,Quality of Life of Colorectal Cancer Survivors in England: Patient Reported Outcome Measures Survey for CPRD GOLD,63.49,ALLIANCE > CPRD,1.1.7,7e9d06a2-efe8-447f-ba3e-d4cbb7df2ef7,cf81a42f-2611-4410-89e9-7e3770d03a15,Not Rated,49.42
67.47,20.93,Bronze,20.63,64.29,NIHR BioResource: Full Blood Counts,55.56,ALLIANCE > NIHR BIORESOURCE,1.1.7,c20c2d81-c2d3-47cc-be38-93074467544c,cf8a9d13-0ee9-494d-b50d-cef39e7823c8,Bronze,71.68
86.5,20.93,Silver,25.4,92.86,Referral to Treatment Times,98.41,ALLIANCE > SAIL,1.1.7,0bf54842-c1db-4bdb-9f55-c5be490bf758,cfdb9fbd-9f67-435c-b257-6b51430451bb,Gold,85.97
69.84,20.93,Bronze,20.63,69.05,Cancer Group CTR Cardiff trials,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,cd833805-f0a8-4ddb-a50d-b12695c92120,d006821e-a507-4699-b560-b5d023e09d4b,Bronze,74.06
81.75,23.26,Silver,23.81,80.95,Mental Health Inpatient and Day Case - Scottish Morbidity Record (SMR04),87.3,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,24de9d1a-1f48-4c10-b8fc-a3bd7449e191,d0137466-d07e-4bfd-817b-198086b9fa13,Silver,78.84
47.62,46.51,Not Rated,50.79,35.71,NHS Tayside and Fife Haematology (Lab Data Restructured),46.03,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,c294bb01-062b-494e-942b-1efe8cbac3dc,d05e9c8c-085e-4907-8688-cad494636ed8,Not Rated,44.6
43.65,55.81,Not Rated,58.73,33.33,Patient Reported Outcome Measures,46.03,ALLIANCE > NHS DIGITAL,1.1.7,55614ed3-2484-4408-a4e9-e5fffed9e8e4,d2af6a29-291b-4444-a17c-40f4208f1e1b,Not Rated,38.76
84.12,25.58,Silver,31.75,95.24,Education - Wales,100.0,ALLIANCE > SAIL,1.1.7,204fa806-071d-4410-9c2c-143017d32d24,d2da2750-7482-4ce9-ae5c-2ab393408a67,Silver,84.83
43.65,32.56,Not Rated,34.92,26.19,Sentinel Stroke National Audit Programme Clinical Dataset,22.22,ALLIANCE > HQIP,1.1.7,059a6495-a7d5-435b-8e2b-806c6ccccf2e,d3673b75-ec8f-4c2e-8c9b-6ef1d951f978,Not Rated,46.81
65.08,20.93,Bronze,22.22,59.52,Strategy introducing Pulmonary Rehabilitation for COPD management in rural India,52.38,HUB > BREATHE,1.1.7,e8afaf39-86fa-4085-a075-6118cc25fae0,d3e859ba-cfb0-4eda-a14c-34b08d113cd9,Not Rated,69.3
37.3,39.53,Not Rated,39.68,16.67,JANUS,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,6590f79d-cfea-4695-9fe0-dc5f85e6d273,d3fd4dac-2d15-401c-8185-905ee108d9ce,Not Rated,38.57
68.25,18.6,Bronze,20.63,66.67,Exploration of Pneumonia Related Policy Formation and Implementation in Pakistan,57.14,HUB > BREATHE,1.1.7,e0d00cb7-62e1-4a38-8df6-cf537b59228d,d5446d68-2fb9-4f0f-962e-7b7ed484d534,Bronze,74.03
56.35,27.91,Not Rated,25.4,40.48,Accelerometer,38.1,ALLIANCE > UK Biobank,1.1.7,ceab57e8-1e13-499b-a8f4-6ad60dad3721,d5649a81-5e75-45c2-ab89-3ce91f6d288b,Not Rated,56.28
37.3,39.53,Not Rated,39.68,16.67,OUH Patient Master Index,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,5d7465f6-ced8-434b-9907-d357ad125024,d57a096a-4fa3-4529-b508-0b9df0f1893c,Not Rated,38.57
59.52,25.58,Not Rated,23.81,47.62,INTERVAL,42.86,OTHER > The University of Cambridge,1.1.7,c1fa9b47-a954-4587-a0c2-bae0f3ec2b9b,d58d02f1-47c2-44fc-b16e-4f6cbbb46e62,Not Rated,61.02
62.7,32.56,Not Rated,36.51,52.38,TRACK-COVID,61.9,OTHER > UNIVERSITY OF CAMBRIDGE,1.1.7,9e89af6b-bfa8-43dc-a2d4-5540c899a670,d614f4fc-fae9-4775-86d9-4d4710017cf4,Not Rated,59.91
69.05,23.26,Bronze,22.22,69.05,UNIRAD UK Sample collection,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,a1d16f3f-c7e7-41c5-a071-07889bf49ab1,d6296f3e-ccd9-46a5-acc9-50eb5aa41c56,Bronze,72.89
84.92,23.26,Silver,26.98,92.86,IBD NIHR BioResource: Demographic,96.83,HUB > GUT REACTION,1.1.7,b4121feb-f91b-4e20-a19b-fa49c7a5c1c1,d711d67c-7f48-4f9c-b482-ac3ed83f7990,Silver,84.8
82.54,25.58,Silver,25.4,83.33,Outpatient Appointments and Attendances - Scottish Morbidity Record (SMR00),90.48,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,04cb9964-54fb-4529-b09b-735c3daa1c7b,d8043751-28d6-4cfe-b860-757e592ab3cb,Silver,78.88
46.83,41.86,Not Rated,38.1,33.33,Cancer Patient Experience Survey (CPES) for CPRD Aurum,31.75,ALLIANCE > CPRD,1.1.7,fded6e24-8fef-47a4-a65e-9455bed043d3,d90830f4-5aaa-4075-8c8d-839627224d16,Not Rated,45.73
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry -  Abdominal Aortic Aneurysm Repair clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,fbe1ae63-0c12-48e5-be16-87d6bc7bd179,da4d3e21-3d81-49e9-ada0-6175e2341190,Not Rated,47.98
89.69,18.6,Gold,20.63,95.24,Looked After Children Wales,100.0,ALLIANCE > SAIL,1.1.7,cfdafacb-48f0-4ad8-9f20-193a5eec2da4,da5098df-414f-48e0-aaa7-7e2277f80eb7,Gold,88.32
69.84,20.93,Bronze,20.63,69.05,King's Health Partners Cancer Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,a218d0b4-0273-4a04-ba17-c01dae6dcf33,da9cdc4c-2790-47f4-b4b5-76e87ce450ae,Bronze,74.06
76.19,30.23,Bronze,33.33,78.57,NIHR BioResource: Sample holding,85.71,ALLIANCE > NIHR BIORESOURCE,1.1.7,56993820-96e4-4a1f-9de1-bad53108c201,dad781b9-43c2-4e8b-a377-e6c0f76d1c04,Silver,74.17
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4.1 (Sensitive) Events,77.78,ALLIANCE > NHS DIGITAL,1.1.7,a1154967-a80e-41da-a9ae-6183584ecf6b,db113fcd-69a0-4357-9c6d-250085deb3f5,Not Rated,56.57
40.48,37.21,Not Rated,36.51,21.43,"NHS Tayside, A&E Drugs given during an A&E visit",17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,acfbef89-344c-49a5-8079-7344f4316e0f,dba474a3-90c4-423d-beb0-5ef79c490d24,Not Rated,42.11
76.19,30.23,Bronze,36.51,80.95,ONS 2011 Census Wales (CENW),88.89,ALLIANCE > SAIL,1.1.7,fc24482c-0f9b-445f-af7a-8598627c3b15,dbd69f22-2638-42a6-a936-069386e8eb7e,Silver,75.36
71.43,20.93,Bronze,20.63,71.43,NHS Greater Glasgow & Clyde Bio-Repository,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,762976cc-83d0-4b31-a879-37f87f947406,dcb4c87b-5884-41c0-b9af-d7d094dd0922,Bronze,75.25
40.48,37.21,Not Rated,36.51,21.43,"NHS Tayside A&E, Diagnosis dataset during A&E visit",17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,14a39e96-8ac3-4df3-b42b-07718121c585,dd0ae281-e3b1-48fb-ad7a-c46565b577ce,Not Rated,42.11
69.84,20.93,Bronze,20.63,69.05,MesobanK,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,b03835b7-7408-49a0-a9aa-ea405f9855c9,ddbc149a-db56-41de-bd2c-3624149f6e7e,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Vascular Registry Audit Carotid Endarterectomy Clinical Dataset,22.22,ALLIANCE > HQIP,1.1.7,f857055b-c29e-4c7f-99ce-65f4ed59648e,ddc965e7-6f52-4eed-bed5-657e3e7bbeac,Not Rated,47.98
69.84,20.93,Bronze,20.63,69.05,NIMRAD-TRANS,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,039b55f7-d416-49ab-9bdb-4ff7dbc733df,ddd49721-ff49-4f68-b3f5-e95a417fb0ac,Bronze,74.06
44.45,32.56,Not Rated,33.33,26.19,National Bowel Cancer Audit -  Organisational Survey dataset,22.22,ALLIANCE > HQIP,1.1.7,4e232aa8-ad56-4d82-adcc-cd06715a5c45,de19b3ea-2600-4472-85e8-628e7beff76e,Not Rated,46.81
75.4,32.56,Bronze,31.75,76.19,Medicines dispensed in Primary Care (NHSBSA data),82.54,ALLIANCE > NHS DIGITAL,1.1.7,f201b68f-d995-4a70-a9ee-aa3510232777,de28157e-5319-4972-83ae-4d0c73cdfca9,Bronze,71.81
74.6,16.28,Silver,15.87,73.81,Children's Health in London and Luton (CHILL),65.08,HUB > BREATHE,1.1.7,722be723-04bd-48b4-923b-e7d393f0c22b,de4b46f5-1591-442d-a896-6e0d91657c01,Bronze,78.77
80.96,9.3,Silver,9.52,80.95,UK Lung Volume Reduction Surgery,71.43,HUBS > BREATHE,1.1.7,9f98a674-12f6-42f4-b1a5-322b3b75eef1,def6669b-0fac-485c-84b2-2ea83ec31123,Silver,85.83
84.12,27.91,Silver,31.75,95.24,Children’s Kidney Cancers - Great Ormond Street Hospital,100.0,HUB > DATA-CAN,1.1.7,3f71bef5-c5a2-400c-a482-2ad30b29a240,df23aabd-3e5f-4fc2-aad6-af990cff6f19,Silver,83.66
80.95,27.91,Silver,33.33,90.48,IBD NIHR BioResource: SNP chip data,95.24,HUB > GUT REACTION,1.1.7,3c749cfc-4008-4916-b64f-969d6a754c0f,df3cc57d-08ae-4e81-ae79-283d71cf8d95,Silver,81.28
78.57,27.91,Silver,31.75,80.95,School Workforce Annual Census (SWAC),88.89,ALLIANCE > SAIL,1.1.7,5692eade-5738-48ed-8527-39be9caaa7b5,df514642-bf9d-432f-bf15-4d870fe4ae08,Silver,76.52
65.88,20.93,Bronze,23.81,64.29,Klang Asthma Cohort,55.56,HUB > BREATHE,1.1.7,a2eddb27-c8bd-42ae-94f8-2a3026220da3,df63e893-f688-4bb4-956c-cc4354bb4001,Not Rated,71.68
40.48,37.21,Not Rated,36.51,21.43,Tayside Microbiology: Isolations,17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,eaa4bab0-0501-4511-aa2d-4e4fee0f0bf3,dfb14598-b705-48c0-b6ec-4b84fa4ef1d4,Not Rated,42.11
37.3,39.53,Not Rated,39.68,16.67,Admitted Patient Care Dataset,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,b67f0edd-fed2-4d68-a25f-d225759aa3b0,dfb21b3b-7fd9-40c4-892e-810edd6dfc25,Not Rated,38.57
69.84,20.93,Bronze,20.63,69.05,Generation Scotland,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,019fad36-65ea-4d47-8d6d-a47240eeb801,dfc3205c-3079-4e95-93e2-8a3a3beeea5a,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Oesophago-Gastric Cancer Audit - clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,306274ee-a098-43cc-b113-2df8116a8703,e10660af-b420-4e25-8fc9-ea451da1dcfb,Not Rated,47.98
79.36,27.91,Bronze,26.98,78.57,Coagulopathies & arterial/venous thrombosis in COVID patients: an OMOP dataset,85.71,HUB > PIONEER,1.1.7,dd4629c0-14b6-4cba-8dcf-31ec5fea68bb,e22f93fb-bc08-44eb-b292-dc2baf0ad343,Silver,75.33
88.09,20.93,Silver,22.22,92.86,Healthcare Workers Risk Assessment,98.41,ALLIANCE > SAIL,1.1.7,ed131fee-0635-4613-a453-a383d5dd7cec,e2f05904-723a-4d5c-8746-7ab3d1d94eef,Gold,85.97
74.61,30.23,Bronze,33.33,76.19,NIHR BioResource: Consent records,82.54,ALLIANCE > NIHR BIORESOURCE,1.1.7,1fb479b1-98d4-4d7b-91a2-8368ce3dc77c,e2f18151-1bce-4a54-ab32-af6296abdfda,Bronze,72.98
69.05,23.26,Bronze,22.22,69.05,"Leeds Dental Institute/School of Dentistry Leeds, Skeletal Tissues Bank",60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,f94168a1-cab8-4211-90e0-38a241609697,e3373d01-48c6-49bc-8c9b-827831e525b3,Bronze,72.89
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Primary Ankle Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,b8d009d0-0163-4aaf-8bd6-ad363c859862,e38c8d6c-8655-4432-b654-23f89c0bb495,Not Rated,47.98
71.43,20.93,Bronze,20.63,71.43,eLIXIR - Early Life Data Cross-Linkage in Research,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,c8cd0645-b728-4c62-84b8-036c1d8763be,e443bc67-bc8a-430b-88a9-d3380cd2ae38,Bronze,75.25
45.24,30.23,Not Rated,33.33,28.57,Unified Cohorts Research Network,23.81,HUB > BREATHE,1.1.7,cffcf30d-cedb-421b-a5dc-6726633cb99a,e516a359-74a8-4932-b4df-f2cf75eef89d,Not Rated,49.17
77.78,27.91,Silver,36.51,85.71,National Records of Scotland (NRS) - Deaths Data,92.06,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,e600dae2-a83c-4b7a-8d23-af4ac31ca374,e61fce14-617d-4f7b-80aa-468d94c6d897,Silver,78.9
84.92,16.28,Silver,17.46,80.95,Child Health Systems Programme - First Visit,87.3,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,dec04153-f595-41ce-9d7e-5ef0c3fe8289,e6d1012e-4526-4f11-bff0-a24f0afea3aa,Silver,82.34
71.43,20.93,Bronze,20.63,71.43,IDRIS Trial,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,8437b207-c925-4dd1-9478-5af329cd736e,e7979d81-708d-4657-857c-4ca95d05cda2,Bronze,75.25
69.84,25.58,Bronze,30.16,61.9,COVID-19 Staff Testing of Antibody Responses Study (Co-STARS),69.84,ALLIANCE > GREAT ORMOND STREET HOSPITAL,1.1.7,435bfcda-f378-44f6-9387-042d959eb945,e79c5f26-deb0-4531-834d-58912c9fe663,Bronze,68.16
75.39,32.56,Bronze,34.92,76.19,Lifelong Learning Wales Record (LLWR),85.71,ALLIANCE > SAIL,1.1.7,cba62a8d-5917-4912-ad4d-340472f7b904,e7fc3bb6-446b-4267-b563-bf6f94e8dee2,Bronze,71.81
87.3,20.93,Gold,25.4,95.24,Children Receiving Care and Support Census,100.0,ALLIANCE > SAIL,1.1.7,fb3fac03-a428-4b3f-8058-5622e1fd57d8,ea9fa5fb-928d-4736-8fbf-e3b58a49c6d6,Gold,87.16
37.3,39.53,Not Rated,39.68,16.67,Sunquest,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,a80b2567-4755-46f1-bd2a-f3817ce4f10c,eaca9ed1-30b6-4157-8894-8e53efc84849,Not Rated,38.57
73.81,32.56,Bronze,34.92,76.19,NIHR BioResource: Contact detail,82.54,ALLIANCE > NIHR BIORESOURCE,1.1.7,fc2fcaec-bd5b-4d43-9e0c-2fed36eff0e4,eaf84760-348c-4a78-bd9f-489a5813276a,Bronze,71.81
73.02,34.88,Bronze,38.1,76.19,Covid-19 UK Non-hospital Antibody Testing Results,84.13,ALLIANCE > NHS DIGITAL,1.1.7,a77e52cc-d404-45d6-835f-32e2dc46778a,eb403f86-e169-4b40-b1e5-34658b90a4a9,Bronze,70.66
47.62,46.51,Not Rated,50.79,35.71,Deaths General Registrar Office – National Records Scotland,46.03,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,5362cfea-d554-43ba-916a-4460da39cc0c,ecb404b5-2fcb-4b91-a86a-f9f8d25b2ebd,Not Rated,44.6
65.08,20.93,Bronze,22.22,59.52,"Introducing pulse oximetry in IMNCI, primary health facilities in Pune India",52.38,HUB > BREATHE,1.1.7,dae5b81c-db28-414b-9328-5596632a8732,ecc4daf2-e58a-4ebc-9608-4bc741231fb9,Not Rated,69.3
71.43,20.93,Bronze,20.63,71.43,NHS Grampian Biorepository,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,10d0def8-dc03-473f-b60b-4c0dc3642a25,ece82228-9af1-4699-a763-b4608908b645,Bronze,75.25
74.6,27.91,Bronze,26.98,69.05,Patient Medical Card Registration (NI),76.19,ALLIANCE > HEALTH AND SOCIAL CARE NORTHERN IRELAND,1.1.7,4e5ba567-c452-4979-8e2e-865f7df20252,ed02be36-22ff-4796-9394-5dd4524fea12,Bronze,70.57
68.25,23.26,Bronze,23.81,69.05,The PEACE Study,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,33b1a989-5f61-412e-bdae-b551c92d1ed6,ee4a73ef-fb4e-4926-9fcc-db6b44b1447e,Bronze,72.89
84.13,18.6,Silver,20.63,80.95,GP Out of Hours,88.89,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,731dc868-3e79-4722-9b79-6bb8dec9435b,ef3fbf5f-a87c-4f63-8d87-4a5f18fb4301,Silver,81.18
79.37,32.56,Bronze,31.75,83.33,CPRD Aurum,90.48,ALLIANCE > CPRD,1.1.7,1d574c14-1af0-490d-9c4e-be88cfd0e345,ef42201e-deb1-4675-896a-8a0162fe52a8,Silver,75.38
37.3,41.86,Not Rated,41.27,19.05,Freetext Dataset,15.87,ALLIANCE > BARTS HEALTH,1.1.7,0f07f939-1265-4e8b-aaa6-d897d254c2f3,ef727724-6c38-483b-b28d-8e94b5a9d7ac,Not Rated,38.59
43.65,32.56,Not Rated,34.92,26.19,National Cardiac Audit Programme - National Heart Failure Audit,22.22,ALLIANCE > HQIP,1.1.7,834618f3-0c6d-4ed2-abae-39208c6b3080,efbb3bf4-834b-417e-b002-03fc41715e58,Not Rated,46.81
64.29,18.6,Bronze,20.63,57.14,The Malaysian Asthma Hajj Study,49.21,HUB > BREATHE,1.1.7,8187f77f-65e3-435e-ad7e-d7f22e2fcf80,eff41dbc-0ce4-4bfe-b51f-7b2753750332,Not Rated,69.27
78.58,30.23,Silver,33.33,83.33,Welsh Health Survey Dataset,90.48,ALLIANCE > SAIL,1.1.7,e4d8edb3-6e8e-435d-9732-60c83027d8f9,f0fc13b4-f801-4647-82f3-07ed07f26ea0,Silver,76.55
74.6,32.56,Bronze,38.1,80.95,North West London Acute Patient level Data (NWL Acute PLD),87.3,HUB > DISCOVER NOW,1.1.7,0d5a40e6-52c0-43c4-bd9f-f2a803cc8ff6,f2268d4e-0149-4913-9832-0399960eecd4,Bronze,74.19
37.3,41.86,Not Rated,41.27,19.05,"Problems, Diagnosis and Procedures",15.87,ALLIANCE > BARTS HEALTH,1.1.7,51b41359-1558-48df-9950-88f75ca6ac4c,f2b4211b-1af7-46ff-82a3-35b29d1d478e,Not Rated,38.59
60.31,46.51,Not Rated,42.86,50.0,Practice postcode linked deprivation measures for CPRD Aurum,63.49,ALLIANCE > CPRD,1.1.7,9f689ef4-26c6-4f85-80ff-5116974f315a,f3a53f7a-ea93-4b9e-bccd-afe762259044,Not Rated,51.75
69.05,25.58,Bronze,25.4,71.43,National Joint Registry - Primary Knee Replacement dataset,63.49,ALLIANCE > HQIP,1.1.7,d517e6fc-9a88-4647-b787-dcbed3635885,f4915e4b-639c-45ae-9b0f-afab547e1104,Bronze,72.93
79.37,32.56,Bronze,31.75,83.33,GPES Data for Pandemic Planning and Research (COVID-19),90.48,ALLIANCE > NHS DIGITAL,1.1.7,696cfc9f-090d-4328-94ac-140760a77c73,f56d5407-4a7e-420e-8479-87b075da2b39,Silver,75.38
40.48,37.21,Not Rated,36.51,21.43,NHS Tayside and Fife Immunology (Extractable),17.46,HEALTH INFORMATICS CENTRE - UNIVERSITY OF DUNDEE,1.1.7,39055449-c074-4b58-adb2-b1c0d2441c4d,f57d92d9-5288-4b4d-9790-49863e8b9232,Not Rated,42.11
45.23,30.23,Not Rated,31.75,26.19,National Diabetes Inpatient Audit - Harms clinical dataset,22.22,ALLIANCE > HQIP,1.1.7,f1471a45-a6f4-4ed7-96b0-56a1af21086e,f69d1b15-a0b4-461a-8aff-dba56da0791f,Not Rated,47.98
87.3,20.93,Gold,25.4,95.24,Substance Misuse Dataset,100.0,ALLIANCE > SAIL,1.1.7,291c0dd4-0988-42d2-8e0b-878a892add57,f6aa8836-b437-40b6-bd1e-ae20010048dd,Gold,87.16
83.34,27.91,Silver,30.16,92.86,North West London Integrated Care Record (NWL ICR),96.83,HUB > DISCOVER NOW,1.1.7,602d8093-6a1e-42cf-a89c-8bf0d47ecc8c,f6e25ba4-4f7a-436e-a5f9-f0257d45a612,Silver,82.47
71.43,20.93,Bronze,20.63,71.43,PHOTO Translational bladder cancer biorepository,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,07d1b768-78f6-41e8-995a-66afd2549b34,f71e0f89-edf6-4070-9045-6024b00f79ca,Bronze,75.25
65.08,25.58,Bronze,26.98,66.67,Developing and evaluating interventions to improve asthma care: HEAL ASTHMA,57.14,HUB > BREATHE,1.1.7,216924f0-585e-4842-a165-78cf9e0af0aa,f73627e3-bd7c-4be2-81b4-3baf846ab787,Not Rated,70.55
45.23,30.23,Not Rated,31.75,26.19,National Maternity and Perinatal Audit clinical audit,22.22,ALLIANCE > HQIP,1.1.7,1419533e-3d46-4d8a-992b-b5311e6bd27b,f806fe65-79aa-4843-bc56-a08bf14ffcec,Not Rated,47.98
44.45,32.56,Not Rated,33.33,26.19,"Maternal, Newborn and Infant Clinical Outcome Review Programme - perinatal surveillance dataset",22.22,ALLIANCE > HQIP,1.1.7,11deee42-5876-4ebe-acca-e996702e1343,f82b8ca5-5a52-4502-bf78-cfbb718cbe2f,Not Rated,46.81
84.12,16.28,Silver,17.46,78.57,Child Health Systems Programme - 13-15 Month Review,85.71,ALLIANCE > PUBLIC HEALTH SCOTLAND,1.1.7,e77af7a3-32fa-4a08-8455-4fb489e5b64a,f87064b0-cb12-4e6e-a709-52e776a0f6b7,Silver,81.14
80.16,30.23,Silver,34.92,90.48,IBD NIHR BioResource: Case report form,95.24,HUB > GUT REACTION,1.1.7,877a7275-b99d-4ed4-9691-de577e0ab49e,f88440b9-53fc-49df-82dd-9cdd3309bd36,Silver,80.12
64.28,23.26,Bronze,22.22,59.52,Wellcome Sanger Institute: Whole Exome Sequencing,50.79,HUB > GUT REACTION,1.1.7,cd20517c-2f75-40e9-9ee8-563d32624b55,f88fa262-525a-4d8a-94bd-cb6f5e7efbf7,Not Rated,68.13
78.57,27.91,Bronze,26.98,76.19,Ventilation strategies for patients on intensive care,84.13,HUB > PIONEER,1.1.7,1a66dbc1-4f06-455c-85fc-68b372575cad,f8a268c1-831c-4c80-b62c-e254a572b9a0,Silver,74.14
54.77,27.91,Not Rated,26.98,40.48,Real-time Assessment of Community Transmission (REACT) Study 2: COVID antibody,36.51,ALLIANCE > IMPERIAL COLLEGE LONDON,1.1.7,70656016-c1c9-4bc2-93d1-c66341fcdf36,f9959c00-c063-4fbf-933d-755e3b6ecedc,Not Rated,56.28
71.43,20.93,Bronze,20.63,71.43,Tommy's National Reproductive Health Biobank,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,20639743-9a28-43dd-a8af-7571ece2a7f8,f99d82da-13eb-42db-ad0d-348be2173535,Bronze,75.25
70.64,23.26,Bronze,22.22,71.43,PHOENIX DDR-Anti-PD-L1 Trial,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,df94730b-374b-4d91-8116-1c10a7c77c4e,f9c40294-92d8-45cd-b11a-70eb0fc09004,Bronze,74.09
45.24,34.88,Not Rated,34.92,30.95,Genvasc Primary Care Data,25.4,ALLIANCE > UNIVERSITY HOSPITALS OF LEICESTER,1.1.7,f397acff-a7af-4062-8e8b-c85889cc41df,fa179e24-2068-4c34-b73c-230003010e9f,Not Rated,48.04
43.65,32.56,Not Rated,34.92,26.19,National Cardiac Audit Programme - National Adult Cardiac Surgery Audit (NACSA),22.22,ALLIANCE > HQIP,1.1.7,5f37e3c2-b5ac-43eb-8eba-ac94dbbff103,faf7ec31-999a-4d87-9d6d-8837ff2fa486,Not Rated,46.81
61.11,25.58,Not Rated,25.4,57.14,NIHR BioResource: Returned datasets,47.62,ALLIANCE > NIHR BIORESOURCE,1.1.7,261bcf76-8621-4f0d-b2e6-310993d73daa,fb274dd9-27ab-4eac-9432-90373a9837e6,Not Rated,65.78
55.56,30.23,Not Rated,26.98,42.86,Hospital Inpatient data,38.1,UK Biobank,1.1.7,97c68424-dc80-4faa-b777-67c42f92a9b6,fb2a851b-3f1c-4665-bbdb-5461f1f36bca,Not Rated,56.31
89.69,18.6,Gold,20.63,95.24,Breast Test Wales,100.0,ALLIANCE > SAIL,1.1.7,8b9efd45-f56d-4aa3-b2b8-c66ff3813a2b,fb4a069b-fd74-47b2-bbb1-9cde6b590d66,Gold,88.32
63.49,25.58,Bronze,25.4,61.9,NIHR BioResource: Whole Genome Sequencing,52.38,ALLIANCE > NIHR BIORESOURCE,1.1.7,ecb90b4a-6f4f-4398-a4f6-d64891c4a137,fbad23e8-5079-4f11-b8b7-aaa01c0fbc4b,Not Rated,68.16
82.54,25.58,Silver,31.75,92.86,North West London High Cost Drugs Data (NWL HCD),96.83,HUB > DISCOVER NOW,1.1.7,75638d2c-556a-46b6-afcc-7ab425b34679,fc704af0-368b-4dd0-866f-753b6d1dccf8,Silver,83.64
37.3,39.53,Not Rated,39.68,16.67,CellPath,14.29,ALLIANCE > OXFORD UNIVERSITY HOSPITALS NHS TRUST,1.1.7,c4538af4-505f-45df-aeae-788ddfd7cb54,fc7b44f0-eb69-4257-8c07-7516c1210c46,Not Rated,38.57
69.84,20.93,Bronze,20.63,69.05,Infectious Diseases BioBank at King's College London,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,47b544f4-301c-43e0-b347-fc623ea1a8b3,fd2317ea-c729-433b-b578-309118118b78,Bronze,74.06
69.84,20.93,Bronze,20.63,69.05,Bristol Biobank,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,9d56ae46-5955-4f03-a93c-a4a6d9f641ab,fe3f2246-aec4-4be4-8f51-3e5bde80931d,Bronze,74.06
45.23,30.23,Not Rated,31.75,26.19,National Joint Registry - Primary Shoulder Replacement dataset,22.22,ALLIANCE > HQIP,1.1.7,0e903b9e-a329-478a-937c-480eecee4996,fe4662ad-9080-4bd8-8de4-51195d275d5b,Not Rated,47.98
42.86,34.88,Not Rated,36.51,26.19,National Paediatric Diabetes Audit - Parent and Patient Recorded Experience measures,22.22,ALLIANCE > HQIP,1.1.7,b0979e07-3331-408f-853b-5eeba80ce8f9,fe872375-2401-4de1-9650-d4139cf5793a,Not Rated,45.66
80.95,32.56,Silver,33.33,88.1,UHB 100K Genomics patient clinical data including their acute care contacts,95.24,HUB > PIONEER,1.1.7,ceae4fe0-4e98-4e3c-85db-e86539aade81,fed0d62b-f7f7-475c-89c9-67caa374f970,Silver,77.77
69.84,20.93,Bronze,20.63,69.05,REQUITE,60.32,ALLIANCE > TISSUE DIRECTORY,1.1.7,b5217dcb-582f-4914-ae45-9eb3899add30,fede80e2-aea9-4229-8024-39b09110be7b,Bronze,74.06
61.11,51.16,Not Rated,55.56,64.29,Mental Health Minimum Dataset v4 (Non-Sensitive) Records,77.78,ALLIANCE > NHS DIGITAL,1.1.7,b9f24f81-bcf2-4e47-8909-0d5414e2d7a4,ff2c6982-00f3-4483-9fc2-19b3a7211d8d,Not Rated,56.57
71.43,20.93,Bronze,20.63,71.43,IMPORT HIGH trial blood samples,63.49,ALLIANCE > TISSUE DIRECTORY,1.1.7,edafebac-9479-4d2c-b44e-349091d5b35b,ff8231e5-3ede-4844-a21b-b1d05120e07e,Bronze,75.25
67.47,18.6,Bronze,20.63,64.29,Teleconsultation in remote rural India: management of COPD and Asthma,55.56,HUB > BREATHE,1.1.7,de496590-26b3-4e74-bc5e-1ff5c83f5b43,ffc34689-1a81-4f56-9c3f-e62b76d8445b,Bronze,72.84
